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ABSTRACT 
 
Global protein acetylation is a newly discovered phenomenon in bacteria. Of the 
more than 250 acetylations reported in E. coli, many are of metabolic enzymes [1-3]. Thus, 
acetylation could represent a novel posttranslational mechanism of metabolic control. 
Yet, almost nothing is known about the regulation of these acetylations or of their 
metabolic outcomes. Here, we report that the cAMP receptor protein (CRP) regulates 
protein acetylation in E. coli and provide evidence that protein acetylation modulates the 
flux of carbon through central metabolism. When we grew cells in mixed amino acids 
supplemented with glucose and cAMP, global protein acetylation increased in a CRP-
dependent manner and several of the acetylated proteins were central metabolic enzymes. 
Much of this CRP-mediated acetylation required activation region 1 (AR1), a surface 
patch that allows CRP to interact with RNA polymerase. A second surface patch (AR2) 
also was involved, albeit to a lesser degree. These results raise the possibility that CRP 
might regulate the transcription of a protein acetyltransferase. Indeed, a recent report 
suggested that CRP might regulate transcription of the protein acetyltransferase YfiQ 
(also known as Pat) by a mechanism that would require AR2 [4]. We further obtained 
bioinformatic evidence that supports the hypothesis that CRP also could regulate yfiQ 
transcription in an AR1-dependent manner. Since CRP regulates metabolism, we asked if 
YfiQ could influence metabolism. Using Phenotype MicroArray analysis [5], we found 
that a yfiQ null mutant exhibits a distinctive defect during growth on gluconeogenic 
 xii 
carbon sources and a distinct advantage during growth on a carbon source that bypasses 
the need for gluconeogenesis. In vitro acetylation assays identified four substrates of 
YfiQ. Three YfiQ substrates were the strictly irreversible glycolytic enzymes PfkA, 
PfkB, and LpdA. The fourth was CRP itself. We thus hypothesize that CRP activates yfiQ 
transcription, whose protein product acetylates a subset of metabolic enzymes, altering 
their function and shifting the balance between glycolysis and gluconeogenesis. We 
further propose that YfiQ acetylates CRP. Efforts to determine how this acetylation 
affects the CRP-dependent transcriptome are underway. 
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CHAPTER I 
 
 
LITERATURE REVIEW 
 
 
Nε-Lysine Acetylation 
 
 The post-translation modification (PTM) of proteins by acetylation can occur in 
two forms: 1) Nα-acetylation, where an acetyl group from the acetyl donor (acetyl-CoA) 
is transferred to the amino terminus of a protein, or 2) Nε-acetylation, where an acetyl 
group is transferred to the ε-amino group of a lysine residue. Nα-acetylation is a non-
reversible PTM that is rare in bacteria, In contrast, Nε-lysine protein acetylation is a 
reversible PTM that can function to alter protein structure, function, stability, 
localization, and protein-protein interactions [6, 7]. In E. coli, over 250 proteins are 
reported to be post-translationally modified by Nε-lysine acetylation 
[1, 2]. The acetylated 
proteins fall into many different functional classes, including some involved in 
transcription, translation, and metabolism, and some in sensing redox states and heat-
shock stress. Currently, there are only 5 bacterial proteins where the effects of Nε-lysine 
acetylation have been studied in any detail: the signaling protein CheY, the central 
metabolic enzyme Acs, the response regulator RcsB, the α subunit of RNA polymerase 
(RNAP), and the exoribonuclease RNase R [8-17].  
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CheY is the response regulator of the chemotaxis system, and upon 
phosphorylation, binds to the flagellar switch FliM, leading to an increase in the 
likelihood of clockwise flagellar rotation [18]. Acetylation of CheY is thought to occur by 
three mechanisms: 1) spontaneous acetylation, where CheY is able to acetylate itself 
using acetyl-CoA as an acetyl donor (this will be explained in detail in the next section) 
[12], 2) acetylation by the central metabolic enzyme Acs using acetate as the acetyl donor 
[11, 19], or 3) acetylation by a yet undiscovered lysine acetyltransferase (KAT) [13, 20]. 
Acetylation of CheY is hypothesized to affect protein-protein interactions between CheY 
and the rest of the chemotaxis machinery, thereby affecting the ability of E. coli to 
respond to chemotatic signals [10].  
The central metabolic enzyme, acetyl-CoA synthetase (Acs), is responsible for 
converting acetate, adenosine triphosphate (ATP) and coenzyme A (CoA) into acetyl-
CoA, pyrophosphate, and adenosine monophosphate (AMP) [21]. Acetylation regulates 
ACS enzymatic activity. Acetylation of an active site lysine of Acs by the KATs Pat in S. 
enterica and AcuA in Bacillus subtilis inhibits Acs activity, but the mechanism of 
inhibition remains unknown [16, 22]. Deacetylation of Acs results in restored catalytic 
activity, and is regulated by the sirtuin CobB in S. enterica, and the sirtuin SrtN and the 
class I KDAC AcuC in B. subtilis [16, 22-24].   
The response regulator RcsB is part of the Rcs two component system involved in 
regulating complex cellular processes such as flagellar synthesis, cell division, and 
capsule biosynthesis. Posttranslational modification by phosphorylation of RcsB occurs 
on a conserved aspartate residue (D56), which serves as the acceptor of the phosphorelay 
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signal from its cognate sensor kinase RcsC via the histidine phosphotransferase RcsD [25], 
leading to either repression or activation of RcsB-dependent promoters. In vitro studies 
into the effects and regulation of RcsB acetylation have shown that: 1) RcsB acetylation 
occurs on lysine 180 (K180) [17], 2) acetylation of K180 affects RcsB activity, most likely 
by affecting the ability of RcsB to bind to the DNA, and 3) the KAT Pat and the sirtuin 
CobB of S. enterica and their homologs in Escherichia coli are sufficient to regulate 
K180 acetylation and deacetylation, respectively [17]. Data from the Wolfe lab furthers 
these findings. In vivo analysis of RcsB acetylation in E. coli indicates that: 1) CobB is 
required for RcsB-dependent rprA exponential phase transcription, 2) YfiQ, the E. coli 
homolog of Pat, activates rprA transcription, but 3) deletion of yfiQ has no discernible 
affect on RcsB acetylation, 4) in vivo acetylation occurs on multiple RcsB lysines, but 
rarely on K180, and 5) some of these acetylations are sensitive to the presence of the 
sirtuin KDAC CobB and some are not (Hu et al., in preparation). These findings suggest 
the possibility that acetylation of K180 may not affect transcription at the rprA promoter 
and suggest a novel role for acetylation of RcsB in E. coli.  
Acetylation of RNA polymerase core subunits was identified in 2 different global 
acetylome studies [1, 2]. More recently, the Wolfe lab has identified acetylation of RNAP 
on three of these core subunits (β, β’, α). Approximately 30 acetylated lysines were 
detected in E. coli cells grown in an amino acid-based medium (TB) supplemented with 
glucose, but not when the glucose was omitted [14].  Acetylation of K298 of the carboxy-
terminal domain (CTD) of α occurred in a glucose- and YfiQ-dependent manner, while 
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glucose-induced transcription of the stress responsive cpxP promoter required K298 and 
was sensitive to nicotinamide, an inhibitor of CobB [14].  
Acetylation of K291, another α-CTD lysine, is detected when an ackA mutant is 
grown in TB supplemented with glucose [26]. The acetylation of K291 is hypothesized to 
inhibit glucose-induced cpxP transcription, as mutation of K291 to K291A alleviates 
inhibition, while mutation to the acetylation mimic K291Q resulted in a decrease in 
glucose-induced cpxP transcription even in wild-type cells [26]. YfiQ is not involved in 
this behavior, suggesting that either K291 can undergo spontaneous acetylation, or is 
acetylated by a yet unknown KAT [26]. These results show that acetylation of the α-CTD 
can have differential transcriptional effects dependent upon environmental and genetic 
conditions. These manuscripts reporting the effects of acetylation on RcsB and RNAP are 
the first to suggest that acetylation can affect transcription in vivo.  
The exoribonuclease RNase R is known to degrade structured RNAs in E. coli, 
and RNase R activity is regulated, in part, by regulation of RNase R stability [27]. Stability 
of RNase R protein is highest in stationary phase cells, with RNase R in exponential 
phase cells having a half life of approximately 10 minutes [28]. RNase R stability is 
regulated by two components of the trans-translation system: tmRNA and SmpB, which 
both bind to the C-terminal region of RNase R, resulting in instability of RNase R in 
exponential phase cells [27]. Comparison of RNase R protein from exponential and 
stationary phase cells revealed that RNase R was acetylated on K544 in exponential, but 
not in stationary, phase cells. This acetylation is regulated by the KAT YfiQ, and leads to 
tighter binding of tmRNA and SmpB, thus increasing RNase R instability [8, 9].  
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Although much is known about the affects and regulation of CheY, Acs, RcsB, 
the α subunit of RNAP, and RNase R acetylation, there are still more than 245 proteins in 
E. coli reported to be acetylated, whose regulation and effects of protein acetylation 
remain unknown. Interestingly, of all the acetylated proteins identified in E. coli, many 
are enzymes involved in carbon metabolism [1, 2]. In the closely related bacteria, 
Salmonella enterica, lysine acetylation is thought to regulate not only the activity of 
certain central metabolic enzymes, but is also predicted to affect carbon flux through 
central metabolism [3]. While one group investigated the regulation of acetylation of the 
S. enterica central metabolic enzymes GapA, AceE, and AceK, the full effects of 
metabolic enzyme acetylation in S. enterica are not known. However, the evidence 
suggests that metabolic enzyme acetylation has the potential to regulate carbon flux 
between glycolysis and gluconeogenesis [3].  
 
Regulation of Nε- Lysine Acetylation 
Currently, there are two proposed mechanisms by which Nε-lysine acetylation is 
thought to occur: 1) enzymatic regulation of Nε-lysine acetylation and 2) spontaneous 
acetylation of lysines.  
Enzymatic regulation of Nε-lysine acetylation is controlled by two groups of 
proteins: lysine acetyltransferases (KATs) and lysine deacetylases (KDACs). Enzymes 
that acetylate lysines are known as lysine acetyltransferases (KATs). 5 groups of proteins 
have been shown to exhibit KAT activity (reviewed in Hu et al., 2011). Of these, the 
GCN5-like acetyltransferase (GNAT) family is the most widely distributed with over 
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10,000 members identified across all three domains of life [29]. KATs are intimately tied 
to central metabolism because they use the key central metabolite acetyl coenzyme A 
(acetyl-CoA) as the acetyl donor [30]. In E. coli, there are 23 known and putative KATs 
[31]. 
YfiQ (also known as Pat in S. enterica, and Pka and PatZ in E. coli) is the only 
well-studied bacterial KAT, and is known to acetylate the central metabolic enzyme Acs 
both in vivo and in vitro [15], the response regulator RcsB in vitro (Hu et al., in 
preparation) [17], the exoribonuclease RNase R in vitro in E. coli [8] , and is sufficient to 
acetylate the enzymes GapA, AceE, and AceK in vitro in S. enterica [3].  YfiQ is a large, 
98 kD, multi-domain protein, where the N-terminal region of YfiQ has a conserved CoA 
binding domain, and the C-terminus has a conserved GNAT RimL-acetyltransferase 
domain (Figure 1) [32]. RimL is a known ribosomal protein acetyltransferase, and has a 
conserved GNAT domain [33].   
Biochemical characterization of S. enterica Pat indicates several key properties: 
1) isothermal titration calorimetry experiments indicate that Pat has 2 binding sites for 
acetyl-CoA, 2) Pat has high affinity for acetyl-CoA, with a dissociation constant (Kd) of 
0.29 ± 0.03 µM for the first site, and 2.38 ± 0.03 µM for the second site, and 3) Pat 
oligomerizes from a monomer to a tetramer in the presence of acetyl-CoA [32]. It is not 
known if the binding of acetyl-CoA to Pat induces a change in conformation that leads to 
tetramer formation. Furthermore, the mechanism of substrate recognition by Pat has not 
been determined, but there are likely three possibilities: 1) sequence-specific recognition 
of a lysine substrate [1], 2) structural specificity of the area surrounding the lysine, or 3) a  
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Figure 1. Domain structure of E. coli YfiQ. Identification of domains was based on 
Conserved domain database [34] search. The CoA binding domain belongs to the NADP-
Rossman superfamily of CoA-binding proteins. The Acyl-CoA Synthetase (NDP-
forming) domain is generally believed to catalyze the conversion of acetyl-CoA and ADP 
to acetate, ATP, and CoA. The C-terminal GNAT domain catalyzes the N-
acetyltransferase reaction, and is homologous to the RimL GNAT domain  
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combination of the two. Although no evidence exists to suggest the possibility of 
structural specificity regulating substrate specificity, a combination of both structural and 
sequence-specificity is a likely mechanism for substrate recognition, similar to the 
proposed mechanism utilized by histone acetyltransferases [35].  
In bacteria, the regulation of KAT activity remains unknown. However, it is likely 
that KAT activity is tied intimately to the levels of the acetyl donor, acetyl-CoA [30], 
which fluctuate in response to periods of carbon starvation and carbon excess. It is not 
known whether KAT activity changes with nutrient conditions; however, published work 
indicates increases in metabolic enzyme acetylation when S. enterica is grown on glucose 
as the sole carbon source, but not citrate [3]. Furthermore, the Wolfe lab has shown that 
growth of E. coli in TB supplemented with 0.4 % glucose results in an increase in protein  
acetylation relative to growth in TB alone [14]. These results indicate that protein 
acetylation can change in response to altered nutrient conditions. However, it remains to 
be seen if KAT activity does indeed change in response to fluctuations in acetyl-CoA 
levels.  
Although the regulation of KAT activity is still unclear, the regulation of KAT 
expression is being uncovered. In one report, expression of YfiQ was shown to change 
during growth, with detectable YfiQ protein levels during exponential growth decreasing 
over time to undetectable levels in late exponential and stationary phase cells [9]. 
Additionally, there is a report that suggests that the central carbon regulator in enteric 
bacteria, cAMP receptor protein (CRP) could regulate expression of at least one known 
and two putative KATs: YfiQ, YedL, and YjhQ, respectively [4, 36, 37], although it is not 
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known how this regulation occurs. Nevertheless, this relationship between CRP and 
KATs is exciting, because CRP activity also is intimately tied to carbon metabolism via 
availability of its allosteric effector, cAMP. The highest CRP activity occurs during times 
of nutrient limitation, while the lowest activity occurs during carbon excess [5] (e.g. 
exposure to glucose). This relationship between cAMP and KATs may be a conserved 
mechanism across bacteria, by which cells can regulate KAT expression and/or activity, 
as it has recently been shown that cAMP regulates KAT activity in Mycobacterium 
tuberculosis [38, 39].   
Spontaneous acetylation of a bacterial protein was first identified for the 
metabolic enzyme Acs [11]. The chemotaxis response regulator CheY also has been shown 
to spontaneously acetylate [12]. Spontaneous acetylation of CheY and Acs was identified 
using in vitro acetylation experiments where either CheY or Acs were incubated with 
either radiolabeled C14-acetyl-CoA or radiolabeled C14-sodium acetate and ATP, 
respectively [11, 12]. The mechanisms by which spontaneous acetylation is regulated are 
being elucidated. Two possibilities exist: a catalytic event called autoacetylation and 
chemical acetylation that does not involve catalysis. Autoacetylation by 
acetyltransferases has been shown to occur as an intramolecular reaction; i.e., the 
acetyltransferase is capable of catalyzing the transfer of the acetyl group from the donor 
to itself. This is the case for the eukaryotic p300 histone acetyltransferase [40]. 
Autoacetylation also can be an intermolecular process. For example, the P/CAF histone 
acetyltransferase autoacetylates by a mechanism in which one P/CAF protein acetylates 
another P/CAF protein in trans [41].  
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Chemical acetylation is seen when the addition of acetyl-CoA, acetic anhydride, 
or sodium acetate and ATP, induces protein acetylation in vitro, as seen with CheY and 
Acs, respectively [11, 12, 42]. It is not understood how proteins can undergo chemical 
acetylation without a KAT being present. Evidence suggests that acetyl-CoA, acetic 
anhydride, and sodium acetate can act as acetyl-donors in vitro. Whether this is the case 
in vivo remains to be seen.  
Lysine deacetylases (KDACs) deacetylate acetylated lysines. There are two major 
families of KDACs, grouped into four classes, for each of which there are putative 
bacterial homologues [43, 44]. The only studied KDAC in bacteria, however, is the sirtuin 
CobB (a member of class III KDACs). CobB is a NAD+-dependent deacetylase (Figure 
2), which is reported to deacetylate the following bacterial proteins in vitro: RcsB, GapA, 
AceE, and AceK, and in vivo: CheY and Acs [3, 16, 17, 20]. The dependence on NAD+ to 
deacetylate certain acetylated proteins and the current knowledge of the CobB-regulated 
metabolic substrates indicates that CobB activity may also respond to changes in cellular 
metabolic status, but the research to definitively show this has not been done [45].  
Structural research into the mechanism of substrate recognition by CobB has 
determined that substrate-specific binding by CobB involves both the zinc-binding 
domain and a region distal to acetyl-lysine-binding site (Figure 2) [46]. Both sites are 
hypothesized to play a role in determining substrate-specificity. Among the sirtuin class, 
the zinc domain is variable, while the acetyl-lysine binding site is conserved [46]. Thus, 
additional work must be done to elucidate how CobB achieves substrate-specificity.  
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Figure 2. Domain structure of E. coli CobB. Identification of domains was based on 
Conserved domain database [34] search. The NAD-dependent deacetylase domain belongs 
to the silent information regulator 2 (Sir2) superfamily of proteins, which catalyzes 
NAD+-dependent deacetylation.  
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Studies into the regulation of CobB expression have yielded little information: 
CRP, which is hypothesized to regulate expression of 2 putative (yjhQ, yedL) and 1 
known KAT (yfiQ), has not been implicated in regulating expression of cobB. Thus far, 
there are no reports of studies researching the regulation of cobB expression in E. coli.  
 
Overview of Glycolysis and Gluconeogenesis 
Central metabolism of carbon is defined by the utilization of three pathways for 
carbon catabolism: Glycolysis (also referred to as the Embden-Meyerhof-Parnas or EMP 
pathway), the pentose-phosphate-pathway, and the tricarboxylic acid (TCA) cycle [47]. 
Glycolysis functions in opposition to a carbon anabolism pathway known as 
gluconeogenesis. Glycolysis and gluconeogenesis are universal pathways that describe 
the catabolism and anabolism, respectively, of the six-carbon monosaccharide glucose.  
 Glycolysis is an anaerobic pathway, in that oxygen is not required for the 
catabolism of glucose, and this pathway is responsible for metabolizing 1 molecule of 
glucose to 2 molecules of pyruvate while producing 2 molecules of ATP [48-50]. Pyruvate 
can be further catabolized by anaerobic or aerobic means using fermentative pathways or 
the tricarboxylic acid cycle, respectively. Under aerobic conditions, pyruvate is oxidized 
to CO2. In anaerobic condition pyruvate is fermented into partially oxidized 
intermediates, e.g. lactate, acetate or ethanol. The central function of the glycolytic 
pathway is to produce energy [48-51].  
The glycolytic pathway consists of ten reactions (Figure 3), and is divided into 3 
stages: 1) stage 1 or the investment stage, where 2 molecules of ATP are utilized for each 
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molecule of glucose taken into the cell with the end product fructose 1,6-bisphosphate; 2) 
stage 2, where 1 molecule of fructose 1,6-bisphosphate is catabolized into two three-
carbon molecules, and 3) stage 3 or the harvesting stage wherein the cell gains four 
molecules of ATP and 2 molecules of NADH from one molecule of glucose [52]. The ten 
different reactions of glycolysis are sequentially as follows. 1) In E. coli, phosphorylation 
of exogenous glucose to glucose-6-phospate is catalyzed by the phosphotransferase 
system (PTS) concomitant with glucose uptake [53]. For intracellular glucose, 
phosphorylation is catalyzed by glucokinase (glk) [53]. In eukaryotes, this reaction is 
catalyzed by the enzyme hexokinase. 2) Reversible isomerization of glucose-6-phosphate 
to fructose-6-phosphate catalyzed by phosphoglucomutase (pgm) [54, 55]. 3) The 
phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, coupled to the 
hydrolysis of ATP to ADP and Pi and catalyzed by the unidirectional enzyme 
phosphofructokinase (pfkA, pfkB) [56]. 4) The catabolism of one molecule of fructose-1,6-
bisphophate into one molecule of dihydroxyacetone phosphate (DHAP) and one molecule 
of glyceraldehyde-3-phosphate (GAP), catalyzed by fructose bisphosphate aldolase 
(fbaA, fbaB) [57]. 5) The interconversion of the isomers DHAP to GAP, catalyzed by the 
enzyme triose-phsophate isomerase (tpiA). 6) Dehydrogenation of GAP to 1,3-
bisphosphoglycerate by the enzyme glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH, gapA) [58]. 7) The generation of ATP and the production of 3-phosphoglycerate 
from 1,3-bisphosphoglycerate catalyzed by phosphoglycerate kinase (pgk) [59]. 8) The 
shift of phosphate from 3-phosphoglycerate to 2-phosphoglycerate catalyzed by 
phosphoglycerate mutase (gpmA) [59]. 9) Dehydration of 2-phosphoglycerate to  
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Figure 3. Glycolysis and Gluconeogenesis [60]. Irreversible glycolytic enzymes are shown 
in unidirectional pink arrows, and irreversible gluconeogenic enzymes are in 
unidirectional green arrows. Reversible glycolytic and gluconeogenic enzymatic 
reactions are denoted with bidirectional arrows in black. Enzyme name and gene 
notations are given for each enzyme.   
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phosphoenolpyruvate catalyzed by enolase (eno) [61]. 10) The irreversible action of 
pyruvate kinase (pykA, pykF) to form pyruvate and to synthesize ATP [62]. Thus, the net 
result of glycolysis is to catabolize 1 glucose molecule into 2 pyruvate molecules, 2 ATP 
molecules, and 2 NADH molecules.  
Gluconeogenesis works in opposition to glycolysis to produce glucose from non-
carbohydrate precursors, such as pyruvate, lactate, glycerol, amino acids and TCA cycle 
intermediates (Figure 3). There are four steps of glycolysis that are irreversible and thus 
need bypass reactions for gluconeogenesis: 1) the conversion of glucose to glucose-6-
phosphate catalyzed by glucokinase (Glk) [53], 2) the synthesis of fructose-1,6-
bisphosphate from fructose-6-phosphate, catalyzed by PfkA and PfkB [63], 3) the 
conversion of phosphoenolpyruvate to pyruvate by 2 pyruvate kinase isoenzymes  (PykA 
and PykF) [64, 65], and 4) the synthesis of phosphoenolpyruvate from oxaloacetate, 
catalyzed by phosphoenolypyruvate carboxykinase (Pck) [66]. To bypass these irreversible 
steps of glycolysis, gluconeogenic carbon sources utilize the following enzymes: 1) the 
conversion of fructose-1,6-bisphosphate from fructose-6-phosphate is catalyzed by four 
isoenzymes (Fbp, GlpX, YbhA, YggF) [67-70], and 2) phosphoenolpyruvate synthetase 
(PpsA) catalyzes the conversion of pyruvate to phosphoenolpyruvate [71].  The rest of the 
glycolytic reactions can work in reverse, and thus these enzymes work in both the 
glycolytic and gluconeogenic pathways. Gluconeogenic carbon sources, once converted 
into pyruvate or PEP through other cellular metabolic processes, are fed into the anabolic 
pathway leading to the production of glucose and other glycolytic intermediates. The 
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conversion of pyruvate to glucose during gluconeogenesis requires the utilization of 2 
molecules of ATP and 2 molecules of NADH.   
 
Regulation of Carbon Flux Between Glycolysis and Gluconeogenesis 
Since glycolysis and gluconeogenesis are interconnected pathways, the flux of 
carbon between the two pathways must be controlled; if both pathways were active at the 
same time, a futile cycle would occur resulting in the net hydrolysis per reaction cycle of 
4 NTPs (2 ATPs and 2GTPs) [52]. Cells utilize a combination of three regulatory 
mechanisms to regulate flux of carbon between these two seemingly opposing pathways: 
1) controlling the concentration of enzymes responsible for the rate-limiting steps of 
glycolysis and/or gluconeogenesis, 2) allosteric regulation of enzymatic activity, and 3) 
covalent modification of enzymes by post-translational modification (PTM) [72]. Thus, the 
in vivo capacity of an enzyme to affect metabolic flux is a function of the enzyme’s 
abundance and its kinetic properties [72, 73].  
 
Regulating the concentration of metabolic enzymes 
Regulating the concentration of metabolic enzymes is most commonly 
accomplished by controlling their expression [72]. In E. coli, there are seven global 
transcriptional regulators (ArcA, CRP, Fis, Fnr, IHF, Lrp, and NarL) [74]. Of these, three 
regulate expression of genes involved in central metabolism: 1) the cAMP-receptor 
protein (CRP) [75], 2) the two component signal transduction pathway ArcB/ArcA, which 
regulates expression of genes in response to redox conditions [76, 77], and 3) the anoxic 
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responsive regulator FNR [76, 78, 79]. There are also two additional regulators of central 
carbon metabolism: the cAMP-independent catabolite repressor-activator Cra [75, 80], and 
the global repressor Mlc, which regulates expression of parts of the glucose 
phosphotransferase system (PTS) [81]. Although expression of metabolic enzymes is 
tightly regulated by CRP, ArcB/ArcA, FNR, Cra, Mlc, or a combination of these 
regulators, research suggests that central metabolic flux is not regulated by controlling 
the expression of metabolic enzymes alone as deletions of each of these regulators does 
not greatly affect metabolic flux [82]. Perrenoud and Sauer systematically deleted ArcA, 
ArcB, Cra, Crp, Cya, Fnr, and Mlc, and tested the affects of each deletion on aerobic 
glucose catabolism using metabolic flux analyses. Only deletion of arcA showed any 
effect on metabolic flux, with TCA activity increasing over 60% when compared to the 
WT strain [82]. Deletion of cra and crp resulted in a growth defect but no significant 
change in metabolic flux when compared to WT [82]. These results indicate that gene 
expression alone does not regulate carbon flux through central metabolism.  
Although deletion of CRP shows little effect on carbon flux [82], CRP is thought to 
play an important role in regulating the flux of carbon, by regulating expression of 
several of the irreversible glycolytic and gluconeogenic enzymes: GlpX, Glk, YggF, 
PpsA, and Pck [83]. These enzymes dictate the entry and exit from the central glycolysis 
and gluconeogenic pathways, leading to the hypothesis that CRP may regulate the switch 
between glycolysis and gluconeogenesis [83].  
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Allosteric regulation of metabolic enzyme activity 
Allosteric regulation of enzyme activity plays an important role in regulating 
carbon flux through glycolysis and gluconeogenesis. This type of regulation exclusively 
modulates the kinetic activity of enzymes via the non-covalent binding of inhibitors or 
activators to non-catalytic sites (allosteric sites) [72]. Inhibition of enzymatic activity can 
occur using many different allosteric regulators: 1) malate and aspartate inhibit Ppc 
activity [84-87], 2) ATP and phosphoenol pyruvate (PEP) inhibit Pck activity [66], 3) ADP, 
AMP malate, oxaloacetate, and PEP inhibit Pps activity [88], and 4) both GTP and 
succinyl coenzyme A inhibit PykA activity [89]. Activation of enzymatic activity occurs 
via a number of different allosteric activators: 1) calcium allosterically activates Pck 
activity [90], 2) fructose-1,6-diphosphate activates PykA [89], and 3) both NMP and ribose-
5-phosphate activate PykF activity [91]. These are just a few of the factors that are known 
to inhibit or activate glycolytic and gluconeogenic enzyme activity; there are many more 
known and unknown factors that are capable of allosterically regulating enzymatic 
activity. Thus, allosteric regulation of enzymatic activity plays a critical role in regulating 
carbon flux through central metabolism [73].  
 
Affects of non-acetylation PTMs on metabolic enzyme activity 
Of the three layers of metabolic enzyme regulation, post-translational 
modifications of enzymes has the ability to affect both enzyme abundance and kinetic 
activity [72].  There are many different types of PTMs that are known to affect metabolic 
enzyme activity, with phosphorylation of enzymes being the most well-understood and 
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studied PTM of metabolic enzymes. The phosphorylation of tyrosine, serine, and 
threonine residues on enzymes serves as an important control mechanism for enzyme 
activity and abundance [92, 93]. The first identified and studied phosphorylation of a 
bacterial metabolic enzyme was that of isocitrate dehydrogenase (ICDH) from E. coli.  
ICDH, a TCA cycle enzyme, catalyzes the conversion of isocitrate into α-ketoglutarate 
[93, 94]. Phosphorylation of ICDH disrupts the binding of the ICDH cofactor NADPH, 
which leads to an almost complete loss in enzyme activity [95-97].  
Besides phosphorylation, other PTMs, such as lysine succinylation, and 
pupylation via the conjugation with the ubiquitin-like protein (PUP), are hypothesized to 
regulate metabolic flux [72]. In E. coli, lysine succinylation has been identified on three 
metabolic enzymes: ICDH, serine hydroxymethyltransferase, and GAPDH [98]. 
Succinylation of these proteins is hypothesized to occur using the succinyl donor 
succinyl-CoA, with succinylation postulated to alter protein structure and function [98]. 
The full effects of lysine succinylation on metabolic enzyme activity and carbon flux, 
however, are not known.   
  Pupylation of proteins occurs when a small protein, Pup, is transferred to the ε-
amino group of a target lysine [99]. Pupylation is considered the bacterial analog of 
ubiquitin modification in eukaryotes. When bacterial proteins become pupylated, they are 
targeted for degradation using archaeal-type mycobacterial proteosome machinery [100-
102]. In bacteria, pupylation has thus far only been identified and studied in 
Mycobacterium tuberculosis, with over 40% of the identified pupylations occurring on 
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metabolic enzymes [103]. To date, there are no studies on the effects and regulation of 
metabolic enzyme pupylation.  
 
Affects of acetylation on metabolic enzyme activity and carbon flux  
 Acetylation of a bacterial metabolic enzyme was first detected on S. enterica 
acetyl-CoA synthetase (Acs) [16]. K609 was found to be reversibly acetylated by the KAT 
Pat and the sirtuin CobB. This acetylation blocks Acs catalytic activity [16]. This 
regulation of Acs acetylation extends to a wide variety of bacteria [15, 22, 39]. It also extends 
to eukaryotes, as the two isoforms of eukaryotic Acs, AceS1 (cytoplasm) and AceS2 
(mitochondria), are acetylated on K661, the residue that corresponds to S. enterica K609. 
Furthermore S. enterica Pat and eukaryotic SIRT1 can regulate AceS acetylation and 
deacetylation, respectively [104, 105]. Acetylation of Acs, whether bacterial or eukaryotic, 
was shown to inhibit its activity both in vivo and in vitro [15, 22, 39].  
Since the discovery of Acs acetylation, proteomic studies in both E. coli and S. 
enterica have provided evidence for acetylation of many additional metabolic enzymes [1-
3]. Of these, many are involved in glycolysis, the TCA cycle, and amino acid and lipid 
metabolism. Similarly, metabolic enzyme acetylation was found to be a highly prevalent 
modification in mammalian liver cells [106-109] and in liver mitochondria [108], suggesting 
the possibility that acetylation may be an ancient mechanism by which cells regulate 
metabolism [60].  
The diversity of acetylated metabolic enzymes suggests that acetylation may 
perhaps serve as a switch that can regulate enzymatic activity [1-3]. In addition to Acs, 
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there are only two other glycolytic and gluconeogenic enzymes where studies to 
understand the effects and regulation of enzyme acetylation have been done: GAPDH, 
and PEPCK. Phosphoenolpyruvate carboxykinase (PEPCK) is a key enzyme that dictates 
the switch between glycolysis and gluconeogenesis, and catalyzes the conversion of 
oxaloacetate to phosphoenolpyruvate. PEPCK acetylation has been studied in yeast, and 
that research reveals that PEPCK acetylation and deacetylation is regulated by the 
nucleosome KAT of the H4 complex, and the KDAC Sirtuin 2, respectively [110]. PEPCK 
acetylation increases under high nutrient conditions, when the cells are fed glucose, and 
decrease in a low-nutrient condition, when cells are solely fed amino acids [109].  
Acetylation of PEPCK affects its activity by regulating the stability, and thereby the 
abundance, of the protein. Under high nutrient conditions, PEPCK is acetylated and thus 
unstable. Stability returns when nutrients become depleted and PEPCK becomes 
deacetylated [109]. It appears, therefore, that PEPCK, and perhaps other metabolic 
enzymes, can respond to changes in environmental conditions, perhaps through the 
actions of its cognate KAT and KDAC.  
Acetylation and deacetylation of GAPDH (also known as GapA) was reported to 
be regulated by S. enterica Pat and CobB, respectively [3], and it is hypothesized that 
acetylation of GAPDH affects flux between glycolysis and gluconeogenesis. Although 
Wang et. al. convincingly show in their study that GAPDH can get acetylated, contrary to 
popular opinion [60], the study did not fully elucidate the in toto affects of GAPDH 
acetylation on metabolic flux. This is because metabolic flux analysis only reveals the 
pathways affected by mutation of either the KAT or KDAC thought to regulate 
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acetylation [3], or of a transcription factor hypothesized to regulate metabolism [82, 111, 112]. 
At best, there is correlative evidence in S. enterica that metabolic enzyme acetylation 
regulates flux, as deletion of the sirtuin cobB resulted in a 47% increase, and deletion of 
the KAT pat resulted in a 40.7% decrease in the glycolysis/gluconeogenesis flux ratio, 
respectively, when compared to the WT strain [3]. Due to the lack of knowledge obtained 
using the singular approach of Wang et al., researchers have proposed that future studies 
should incorporate traditional flux analyses with omics data from transcriptional analyses 
so that instead of assessing individual regulatory events, genome-scale fluxes can be 
estimated through stoichiometric modeling [72], as was performed in yeast [113, 114].  
Thus, the full effects of metabolic enzyme acetylation on 
glycolytic/gluconeogenic flux and central metabolism are not known, and much work 
remains. Our lab aims to further this research by trying to elucidate the mechanisms of 
the regulation of metabolic enzyme acetylation, and to start to elucidate the effects of 
acetylation on carbon flux through central metabolism.  
 
cAMP Receptor Protein, CRP 
 The discovery of the cAMP receptor protein, CRP, occurred when researchers 
tried to identify the components required to regulate β-galactosidase transcription in E. 
coli. Adenosine 3’, 5’-cyclic phosphate (cyclic AMP) was known to regulate β-
galactosidase (lacZ) transcription [115-117], as both biochemical and genetic studies 
indicated that cAMP stimulated lacZ transcription [118, 119], cell-free extracts of E. coli 
were able to produce β-galactosidase in vitro when the extracts were supplemented with 
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lac operon-containing DNA[120], and the addition of cAMP to this system increased β-
galactosidase synthesis [121].  Purification and characterization of a cAMP binding protein 
then followed [122], and this protein, CRP, now serves as a model for transcriptional 
regulation in bacteria.  
CRP is now known as one of the seven global transcription factors of E. coli [123], 
regulating expression of over 200 genes or roughly 5% of all E. coli genes [124].  CRP is 
activated upon binding of the second messenger cAMP, in response to the advent of 
carbon starvation. When bound by cAMP, the CRP dimer binds its DNA sites with high 
affinity and, as such, can either activate or repress transcription depending on promoter 
context.  
CRP regulates transcription by using three surface-exposed patches known as 
activating regions that interact with RNA polymerase (RNAP) to control gene expression 
from various promoters (Figure 4a) [123]. Transcription activation by CRP at the simplest 
promoters occurs when CRP binds to a consensus site [125], centered at about 60, 70 or 80 
(Class I) or at about 40 (Class II) base pairs upstream of the transcription start site (+1) 
[126]. At Class I promoters, activating region 1 (AR1) interacts with the C-terminal 
domain of the α subunit of RNAP (α-CTD) (Figure 4b) [126, 127]. At Class II promoters, 
the α-NTD (N-terminal domain of the α subunit of RNAP) interacts with the activating 
region 2 (AR2) (Figure 4c). At some Class II promoters, the AR1/α-CTD interaction 
also participates in transcription initiation [126, 128-131]. At other Class II promoters, an 
interaction between AR3 and the σ subunit of RNAP participates. Of the three activating 
regions, AR2 & AR3 contain charged residues that, when disrupted, result in altered 
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interactions between CRP and RNAP, leading to a change in gene expression from CRP-
activated promoters. We will discuss the AR2 and AR3 interactions with RNAP in detail, 
and thus, we will focus on CRP-dependent transcription from Class II promoters.   
  
Interactions between Activating Region 2 and RNA polymerase 
At Class II CRP-dependent promoters, CRP interacts with RNAP polymerase in 
three different places: AR1 makes contact with the α-CTD of RNAP, AR2 makes contact 
with the α-NTD of RNAP, and AR3 can make contact with domain 4 of the σ70 subunit 
of RNAP (Figure 4c) [128]. Detailed and elegant work by several researchers has 
elucidated the different mechanistic consequences of the AR1 and AR2 interactions on 
CRP-dependent transcriptional activation. At Class II CRP-dependent promoters, the α-
CTD acts as an inhibitory determinant, and the AR1-α-CTD interaction overcomes the 
inhibitory effect of the α-CTD, resulting in an increase in binding between RNAP and the 
DNA [132, 133]. Thus, the AR1-α-CTD interaction allows the formation of the transcription 
closed complex (TCC) [126].   
The AR2-α-NTD interaction increases the rate of isomerization from the TCC to 
the transcription open complex (TOC), by stabilizing the transition state between the 
TCC and the TOC [128]. AR2 is a surface exposed patch of CRP consisting of the 
following residues: Histidine-19, Histidine-21, Glutamate-96, and Lysine-101 [128, 132]. 
These residues interact with a string of four negatively charged residues on the α-NTD: 
Glutamate-162, Glutamate-163, Aspartate-164, and Glutamate-165 [128].  
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Figure 4. Regulation of transcription by cAMP receptor protein (CRP). A) Structure of 
the CRP-DNA complex showing AR1 in blue, AR2 green, and AR3 in olive green. B) 
Transcription activation can occur by a Class I mechanism, where CRP binds to an 
upstream site centered near positions –61, -71, -81, -91 and interacts through Activation 
Region 1 (AR1, 1) with an α-CTD C). Activation can also occur via a Class II 
mechanism, where CRP binds a site near the –35 hexamer and interacts with RNAP via 
two surfaces: activating region (AR1, 1) and Activation Region 2 (AR2, 2). Figures 
adapted from Wolfe (2009), and Lawson et al. (2004).  
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This interaction between AR2 of CRP and residues 162-165 of the α-NTD 
appears to be electrostatic in nature, with the distance between the two proteins dictating  
the strength of the interaction [128]. This indicates that both charge and size of the amino 
acid residues on both CRP and RNAP are required to maintain the needed interactions. 
Thus, mutation of any of the residues required for participating in this interaction leads to 
a disruption of the electrostatic interaction, and consequently, loss of transcription from 
CRP-dependent Class II promoters [128]. 
 Specifically, mutation of the charged residue K101 residue in AR2, to the 
uncharged and smaller residue alanine (K101A), or charge reversal to a glutamate 
(K101E) results in loss of transcription from Class II promoters [134]. These results 
indicate that the positive charge of K101 is likely required for Class II transcriptional 
activation [134]. Interestingly, K101 was one of two residues of CRP whose acetylation 
was identified using mass spectrometry of whole cell lysates of E. coli [1, 2]. While the 
regulation and effects of K101 acetylation are not known, acetylation of K101 would be 
predicted to neutralize the charge of the K101 [135, 136] and, as previous studies have 
shown, the charge of K101 is required to maintain the electrostatic interactions between 
AR2 of CRP and the αNTD of RNAP [128, 132]. We therefore hypothesize that acetylation 
of K101 leads to a disruption in the electrostatic interactions between AR2 and the 
αNTD, resulting in loss of transcription from Class II promoters.  
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Interactions between Activating Region 3 and RNA polymerase  
 AR3 of CRP is a complex region of CRP, containing both an activating determinant 
consisting of the negatively charged residues Aspartate-53, Glutamate-54, Aspartate-55, 
and Glutamate-58, and an inhibitory determinant consisting of the positively charged 
residue Lysine-52 [130, 131, 137-139]. The residues of AR3 interact with a positively charged 
patch of residues on domain 4 of σ70 subunit of RNAP, consisting of residues Arginine-
596, Arginine-599, Lysine-593, and Lysine-597 [130]. Specifically, the side chains of 
K593, K597, and R599 are thought to form a cluster that interacts with residues K52-D55 
and E58 of AR3 of CRP (Figure 5). R596 of domain 4 of σ70 is thought to be separate 
from the cluster, and clashes with the inhibitory residue K52 of AR3.  
 Thus, AR3 residues 53-55 and 58 increase the rate of isomerization from the TCC 
to the TOC at CRP-dependent Class II promoters, while K52 plays an inhibitory role at 
these promoters [130, 131]. The positively charged K52 interacts with a positively charged 
surface of RNAP, sterically preventing tight interactions between the two proteins. 
Mutation of the charged K52 residue on AR3 to an uncharged asparagine (N52) results in 
a tighter interaction between CRP & RNAP, because the negatively charged residues on 
CRP can interact with the positively charged residues on RNAP [130, 131]. Thus, 
neutralization of the charged K52 permits a tighter interaction between the two proteins. 
AR3, therefore, consists of activating and inhibiting determinants that balance each other, 
so that at Class II promoters, the dominant interactions between CRP and RNAP occur 
via AR1 and AR2 [130, 131]. 
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 Proteomics studies identified acetylation of CRP at two locations, K101 (as 
described above) and K52 [1, 2]. Acetylation of K52 would be predicted to neutralize its 
charge [135, 136] and thus could play a physiologically relevant role similar to that of the 
K52N mutation - by neutralizing K52, acetylation would permit a tighter RNAP-CRP 
interaction, and lead to a change in transcription from Class II promoters. Thus, CRP 
acetylations of K52, or K101, or both K52 and K101, have the potential to impact gene 
expression from a wide variety of CRP-dependent Class II promoters, and further the 
mechanistic understanding of how CRP regulates Class II-dependent transcription.  
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Figure 5. Proposed interactions between AR3 and the σ70 subunit of RNAP that may 
regulate transcription from a Class II CRP-dependent promoter. AR3 lies within an 
exposed β-turn, with the large arrowhead depicting the direction of the C-terminus of the 
peptide chain. AR3 residues D53, E54, and E55 form a negatively charged patch, and 
residues K52 and E58 are adjacent to each other. σ70 residues are located on an α-helix, 
with the large arrowhead depicting the direction of the C-terminus of the peptide chain. 
σ70 residues K593, K597, and R599 form a positively charged cluster. Interactions 
between AR3 and σ70 are indicated as follows: productive (double headed arrows), non-
productive (line with perpendicular ends), and weak interactions (dotted line). Figure 
adapted from Rhodius & Busby (2000). 
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Summary 
 
Lysine acetylation is a post-translational modification that affects proteins in 
many different ways, and thus has a significant impact on many different aspects of 
cellular physiology. In bacteria, lysine acetylation is a relatively newly discovered 
phenomenon, and much remains to be elucidated concerning the regulation of 
acetylation, the effects of acetylation on various cellular processes, and the evolutionary 
costs and reasoning for the conservation of acetylation across the three domains of life.  
 We wish to understand the regulation and effects of metabolic enzyme acetylation 
in the enterobacterium E. coli. It is known that metabolic enzyme acetylation occurs in E. 
coli, but much remains unknown concerning both the mechanisms that regulate 
acetylation and the downstream effects of acetylation on enzyme function and carbon 
flux through central metabolism. Furthermore, we aim to understand the regulation and 
effects of acetylation of the transcriptional regulator CRP, as this transcription factor 
responds to and regulates carbon metabolism and has been implicated in potentially 
regulating acetylation in E. coli.  
 The goal of my thesis project is to start the process of elucidating the factors that 
regulate metabolic enzyme acetylation, and attempt to understand how metabolic enzyme 
acetylation affects metabolism. There is research in eukaryotes, and preliminary research 
in S. enterica, suggesting that acetylation serves to regulate carbon flux through central 
metabolism, but significant work needs to be done to fully understand the effects of 
metabolic enzyme acetylation on central metabolism.  
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Our lab has shown that acetylation of RNAP and RcsB can affect gene expression 
from at least two promoters, cpxP and rprA, respectively. Acetylation of CRP is predicted 
to affect expression of at least some of the Class II-CRP-dependent-genes, and we hope 
to elucidate some of the effects of CRP acetylation on Class II-gene expression.
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MATERIALS AND METHODS 
 
 
Bacterial strains and plasmids 
All bacterial strains used in this study are listed in Table 1. Derivatives were 
constructed by generalized transduction with P1kc, as described previously [140]. Plasmids 
used in this study are listed in Table 2. Oligonucleotide primers used in this study are 
listed in Table 3.  
 
Culture conditions 
For strain construction, cells were grown in Luria-Bertani (LB) containing 1% 
(wt/vol) tryptone, 0.5% (wt/vol) yeast extract, and 0.5% (wt/vol) sodium chloride. LB 
plates also contained 1.5% agar. For Western immunoblot analysis, cells were grown in 
buffered TB that contained 1% (wt/vol) tryptone buffered at pH 7.0 with 100 mM 
potassium phosphate (TB7). Cell growth was monitored spectrophotometrically (DU640; 
Beckman Instruments, Fullerton, CA, USA) by determining the optical density at 600 nm 
(OD600). Kanamycin (40 µg ml-1), ampicillin (100 µg ml-1), and chloramphenicol (25 µg 
ml-1) were added as needed.  
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Western immunoblot analysis 
To observe the differences in protein acetylation profiles, 10 ml cell cultures were 
grown at 37oC with agitation at 250 rpm in TB7 for 7.5 hours (to allow entry into 
stationary phase). Cells were harvested and pelleted by centrifugation and pellets 
resuspended with Tris-EDTA pH 8.0. Samples were lysed by sonication, and the proteins 
separated by SDS-12% polyacrylamide gel electrophoresis (PAGE), transferred to PVDF 
membranes, and subjected to Western immunoblot analysis. Two polyclonal anti-
acetyllysine antibodies were used: Cell Signaling Technology at a 1:200 dilution, and 
ImmuneChem at a 1:500 dilution. Primary incubation was carried at 4oC with shaking, 
followed by 4 washes for 5 minutes each in phosphate buffer with 1% Tween (PBST). 
Secondary goat anti-rabbit Immunoglobulin G antibody at a 1:1000 dilution conjugated 
to horseradish peroxidase was incubated for 2 hours at room temperature with shaking, 
followed by 3 washes for 5 minutes each in PBST. Enhance chemiluminescence Western 
immunoblotting reagents (LumiGlo, Cell Signaling Technology) were used for 
visualization, according to manufacturer’s instructions. When needed, OneMinute 
Western Blot Stripping Buffer (GM Biosciences) was used to strip membranes, according 
to manufacturer’s instructions.  
 
Phenotype MicroArrayTM assays 
 Metabolic Phenotype MicroArrayTM assays were performed as previously 
described [5, 141]. Briefly, bacteria were resuspended from LB plates into 10 ml of IF-0a 
GN/GP Base IF (Biolog Inc.) to an 85% transmittance, and PM media was prepared 
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according to manufacturer’s instructions. PM1 and PM2 microplates (Biolog Inc.) were 
inoculated with 100 µl of PM media containing the bacterial suspension and incubated at 
37oC for 48 hours in the Omnilog Incubator (Biolog). OD600 measurements were taken 
at 15 minute intervals (OmniLog PM DC 1.30.01), and OmniLog PM software was used 
for data analysis and kinetic and parametric plot generation. Parametric plot generations 
of three independent experiments comparing mutant and wild type strains was used to 
generate average plot height for data comparisons using a significance threshold >20, as 
per manufacturer’s instructions.  
 
Growth curve analyses 
To determine the effects of mutation of genes encoding putative and known KATs 
on carbon metabolism, we grew cells in 25 ml of TB7 supplemented with and without the 
following carbon sources: 0.4% glucose (w/v), 0.8% lactate (w/v), 15 mM acetate, 0.6% 
succinate (w/v), 0.8% glycerol (v/v), under different oxygenation conditions: either high 
levels of oxygenation or aeration, corresponding to 250 rpm, medium levels of 
oxygenation, 100 rpm, or static cultures for low levels of oxygenation, or microaerophilic 
conditions. Cultures were grown for 8-10 hours, with OD600 readings taken every 30 
minutes.  
 
Expression and purification of proteins  
Chloramphenicol resistant ASKA plasmids [142] for YfiQ, RcsB (our positive 
control, see Hu et al., in preparation), and our metabolic enzymes were purified from the 
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ASKA collection and transformed into kanamycin resistant BL21 Magic cells [143].  
Protein was expressed in the presence of 34 µg/ml chloramphenicol and 35 µg/ml 
kanamycin and purified as described (Kuhn et al., 2012, in preparation).  Since the 
ASKA clones did not contain a cleavable polyhistidine affinity tag, we cloned the yfiQ, 
rcsB, pfkA, pfkB, and lpdA genes into the pMCSG7 vector [143, 144], which contains a 
tobacco etch virus cleavage site after the N-terminal polyhistidine tag. All assays were 
performed using the protein produced from ASKA clones because we did not obtain 
soluble expression of the pMCSG7 clones and therefore could not remove the tag. 
In vitro acetylation assay 
Purified YfiQ and potential substrates were incubated in Tris-HCl buffer pH 8 
with the following components: 50 mM Tris-HCl pH 8.0, 10% glycerol (v/v), 0.1 mM 
EDTA, 1 mM DTT, and 10 mM sodium butyrate. Each reaction mixture was prepared 
just prior to use in a total reaction volume of 100 µl and reactions were incubated for 2 
hours at 37oC in a water bath. 2x SDS loading buffer was added to stop the reaction, and 
samples were heated for 5 minutes at 100oC to denature proteins. Proteins were then 
separated by 12% SDS-PAGE. To compare the acetylation state of proteins before and 
after incubation with YfiQ, anti-acetyllysine Western immunoblot analysis was 
performed using the method described above.  
 
Ellman’s assay  
Biochemical assays were performed as described previously (Kuhn et al., 2012, in 
preparation) with some modifications.  First, reactions were performed in the presence of 
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0.15 mM NaCl at 25oC for 1 hour to prevent protein precipitation during the reaction.  
Additionally, after stopping the reactions with guanidine HCl samples were transferred to 
Nanosep 10K MWCO centrifugation devices (Pall Life Sciences, VWR) and centrifuged 
at 13,000 rpm for 10 minutes to separate CoA and the protein.  The Ellman’s reagent was 
then added to the flow-through and monitored as described (Kuhn et al., 2012, in 
preparation). High concentrations of YfiQ (100 µg) were necessary to detect activity (see 
note in cloning section of methods), most likely due to the polyhistidine tag competing 
with binding of AcCoA.   
Promoter activity assays 
To monitor promoter activity from Pacs205-lacZ [145], or PCC-41.5-lacZ [146], 
cells were grown in TB7 or TB7 supplemented with various carbon sources for 8 hours. 
Every 60 minutes, 50 µl aliquots were harvested and 50 µl of All-in-One β-galactosidase 
reagent (Pierce Biochemical) was added at the end of the 8-hour experiment. β-
Galactosidase activity was then determined quantitatively using a microtiter format, as 
described previously [147]. 
 
Orbitrap-mass spectrometry and protein identification.  
Either whole cell lysates from complemented CRP strains (AJW 2313), or vector 
control (AJW 4524) strains were run on an 12% SDS-PAGE gel, and gel slices were 
excised and subjected to tryptic digestion, as described previously [148]. Tryptic peptides 
were separated and measured online by ESI-mass spectrometry using a nanoACQUITY 
UPLC™ system (Waters, Milford, MA) coupled to an LTQ Orbitrap™ XL mass 
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spectrometer (Thermo Fisher Scientific, Waltham, MA). A trap column (Symmetry® 
C18, 5 µm, 180 µm inner diameter x 20mm, Waters) was used for desalting. Elution was 
performed onto an analytical column (BEH130 C18, 1,7 µm, 100 µm inner diameter x 
100 mm, Waters) by a binary gradient of buffers A (0.1% (v/v) acetic acid) and B (99.9 
% (v/v) acetonitrile, 0.1% (v/v) acetic acid) over a period of 80 min with a flow rate of 
400 nl/min. The Orbitrap XL was operated in data-dependent MS/MS mode using the 
lockmass option for real time recalibration. Proteins were identified by searching all 
MS/MS spectra in “dta” format against an E. coli database (extracted from the Uniprot-
KB database: 
http://www.uniprot.org/uniprot/?query=Escherichia+coli+K12&sort=score), using  
Sorcerer™-SEQUEST® (Sequest v. 2.7 rev. 11, Thermo Electron including 
Scaffold_3_00_05, Proteome Software Inc., Portland, OR).  
The Sequest search was carried out considering the following parameters: a parent 
ion mass tolerance - 10 ppm, fragment ion mass tolerances of 1.00 Da. Up to two tryptic 
miscleavages were allowed. Methionine oxidation (+15.99492 Da), cysteine 
carbamidomethylation (+57,021465 Da) and lysine acetylation (+42.010571 Da) were set 
as variable modifications. Proteins were identified by at least two peptides applying a 
stringent SEQUEST filter. Sequest identifications required at least ΔCn scores of greater 
than 0.10 and XCorr scores of greater than 1.9, 2.2, 3.3 and 3.8 for singly, doubly, triply 
and quadruply charged peptides. Acetylated peptides that passed these filter criteria were 
examined manually and accepted only when b- or y- ions confirmed the acetylation site 
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TABLE 1. Bacterial strains used in this study. 
Strain  Relevant characteristics    Source/Reference 
AJW678 thi-1 thr-1(Am) leuB6 metF159(Am)   [149] 
 rpsL136 lacX74  
AJW2179 AJW678 λpacs205     [145, 150] 
AJW2198 AJW2179 Δcrp::kan     [145, 150] 
AJW2313 AJW2198 pDCRP     [129, 150] 
AJW2314 AJW2198 pDCRP/K101E    [129, 150] 
AJW2315 AJW2198 pDCRP/K52N    [129, 150] 
AJW2316 AJW2198 pDCRP/K101E/K52N   [129, 150] 
AJW3660 AJW2198 pDCRP/H159L    [129, 150] 
AJW3661 AJW2198 pDCRP/H159L/K52N   [129, 150] 
AJW3763 AJW2316 pCA24N     [142] 
AJW3764 AJW2316 pCoaA      [142] 
AJW3897 AJW2198 pCA24N      [142] 
AJW3898 AJW2198 pCRP (pCA24N)    [142] 
AJW4333 AJW2179 ΔyjhQ::kan           P1:JW4269AJW2179 
         [151] 
AJW4344 AJW2179 ΔyfiQ::kan                                   P1:JW2568AJW2179 
         [151] 
AJW4355 AJW4333 pDCRP     [129, 150] 
AJW4366 AJW4344 pDCRP     [129, 150] 
AJW4456 AJW678 Δcrp::kan             P1:JW5702AJW2179 
[148] 
AJW4524 AJW2198 pBR322/pDU9    [129, 150]   
AJW4525 AJW2179 pBR322     [129, 150]   
AJW4526 AJW2179 pDCRP     [129, 150] 
AJW4527 AJW4333 pBR322     [129, 150] 
AJW4786 AJW4456 pRW50 CC-41.5    [152] 
AJW4787 AJW4456, pDCRP      [129, 150, 152] 
AJW4788 AJW4786 pDCRP/K101E    [129, 150, 152] 
AJW4870 AJW4786 pDCRP/K52N    [129, 150, 152]  
AJW4871 AJW4786 pDCRP/K101E/K52N   [129, 150, 152] 
AJW4872 AJW4786 pDCRP/H159L    [129, 150, 152] 
AJW4873 AJW4786 pDCRP/H159L/K52N   [129, 150, 152] 
AJW4956 AJW4786 pDCRP/K101A    [129, 150]   
AJW4957 AJW4786 pDCRP/K101Q    [129, 150] 
AJW4958 AJW4786 pDCRP/K101R    [129, 150] 
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TABLE 2. Plasmids used in this study 
Plasmid   Relevant Characteristics                   Source/Reference 
pBR322   Control plasmid (AmpR)   [129, 150] 
pDCRP   Plasmid expressing CRP (AmpR)  [129, 150] 
pDCRP/K101E  Plasmid expressing K101E (AR2)  [129, 150]  
variant of CRP (AmpR)  
pDCRP/K52N   Plasmid expressing K52N (AR3)  [129, 150] 
variant of CRP (AmpR)  
pDCRP/K101E/K52N Plasmid expressing K101E/K52N (AR2,3) [129, 150] 
variant of CRP (AmpR)  
pDCRP/H159L  Plasmid expressing H159L (AR1)  [129, 150]  
variant of CRP (AmpR)  
pDCRP/H159L/K52N Plasmid expressing H159L/K52N (AR1,3)  [129, 150] 
variant of CRP of CRP (AmpR)  
pCA24N   Control plasmid (CmR)   [142] 
pCA24N-coaA  Plasmid expressing 6xHis-CoaA under the  [142] 
control of an IPTG-inducible promoter (CmR)  
pCA24N-crp   Plasmid expressing 6xHis-Crp under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-tpiA   Plasmid expressing 6xHis-TpiA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-fbaA   Plasmid expressing 6xHis-FbaA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-maeB  Plasmid expressing 6xHis-MaeB under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-gpmA  Plasmid expressing 6xHis-GpmA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-yjhQ   Plasmid expressing 6xHis-YjhQ under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-lpdA   Plasmid expressing 6xHis-LpdA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pykF  Plasmid expressing 6xHis-PykF under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pgk   Plasmid expressing 6xHis-Pgk under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-mdh   Plasmid expressing 6xHis-Mdh under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pck   Plasmid expressing 6xHis-Pck under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-ppc   Plasmid expressing 6xHis-Ppc under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pykA  Plasmid expressing 6xHis-PykA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
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TABLE 2 (cont). Plasmids used in this study 
Plasmid   Relevant Characteristics                   Source/Reference 
pCA24N-gapA Plasmid expressing 6xHis-GapA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pfkA   Plasmid expressing 6xHis-PfkA under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-pfkB   Plasmid expressing 6xHis-PfkB under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pCA24N-ptsH   Plasmid expressing 6xHis-PtsH under the  [142] 
control of an IPTG-inducible promoter (CmR) 
pPRW50 CC-41.5  Plasmid expressing lacZ under the control  [152] 
    of the semi-synthetic CC-41.5 promoter (TetR) 
pDCRP/K101R  Plasmid expressing K101R variant   [129, 150] 
of CRP (AmpR) 
pDCRP/K101A  Plasmid expressing K101A variant   [129, 150] 
of CRP (AmpR) 
pDCRP/K101Q  Plasmid expressing K101Q variant   [129, 150] 
of CRP (AmpR) 
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TABLE 3. Oligonucleotide primers used in this study 
Target gene   Sequence from 5’ to 3’               
crp 
F: AACAGACCCCAGTCTCGAATCGTT  
R: TACGTTCCTGGCCCTCTTCAAACA 
Purpose: Primer set binds at 5’ and 3’ ends of CRP. Used to verify crp deletions. 
 
yjhQ 
 F: TCAATGGCCAGCCCTATCGAATCA 
 R: TTGCATCATCCAGCAGGCTTTGTG 
Purpose: Primers bind upstream of and in yjhQ gene to verify deletion.  
 
lacZ  GGCGATTAAGTTGGGTAACG               
Purpose: Sequence promoters of pRW50 
 
6XHis  CATTAAAGAGGAGAAATTAACTATGAGAGG   
Purpose: Sequence and verify insertions into pCA24N from ASKA collection. 
 
crp – K101R 
 F: GAAGTGGCTGAAATTTCGTACAGAAAATTTCGCCAATTGATTCAG 
 R: CTGAATCAATTGGCGAAATTTTCTGTACGAAATTTCAGCCACTTC 
Purpose: Used to construct site directed mutant of K101 to K101R.  
 
crp – K101A 
F: GTGAAGTGGCTGAAATTTCGTACGCAAAATTTCGCCAATTGATTCAGG 
R: CCTGAATCAATTGGCGAAATTTTGCGTACGAAATTTCAGCCACTTCAC 
Purpose: Used to construct site directed mutant of K101 to K101A.  
 
crp – K101Q 
F: GTGAAGTGGCTGAAATTTCGTACCAGAAATTTGGCCAATTGATTCAGGT 
R: ACCTGAATCAATTGGCGAAATTTCTGGTACGAAATTTCAGCCACTTCAC 
Purpose: Used to construct site directed mutant of K101 to K101Q.
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CHAPTER III 
 
 
RESULTS: CRP=DEPENDENT REGULATION OF  
PROTEIN ACETYLATION IN E. coli. 
 
 
In eukaryotes, protein acetylation regulates many cellular functions, including 
gene expression, protein degradation, and enzymatic activity [153]. In bacteria, the effects 
of protein acetylation are not understood. Recent reports, however, indicate that protein 
acetylation has the potential to regulate many aspects of cellular physiology [3, 13, 154]. 
Although it is now clear that bacterial protein acetylation occurs [1-3], the following 
remain unknown: 1) the mechanism by which the cells regulate the majority of protein 
acetylations, and 2) if these acetylation events affect cellular physiology. In this chapter, I 
aim to elucidate both the regulation and the effect of lysine acetylation of several proteins 
in E. coli.  
Two types of enzymes regulate protein acetylation: lysine acetyltransferases 
(KATs) and lysine deacetylases (KDACs). Lysine acetyltransferases catalyze protein 
acetylation, and these enzymes have been implicated in a number of acetylation events in 
bacteria [3, 30]. The cAMP receptor protein (CRP), the major carbon regulator of enteric 
bacteria, e.g. E. coli, is reported to regulate expression of at least three KATs: 2 putative 
(YedL and YjhQ) and one known (YfiQ) [4, 37]. Because it can regulate transcription of 
43 
 
genes that encode KATs, we hypothesized that CRP regulates protein acetylation in E. 
coli. If so, these acetylation events should impact central metabolism and other CRP-
regulated cellular processes. This chapter describes experiments to test this hypothesis 
and, if it is correct, to identify the requirements for CRP-dependent acetylation.  
 
Characterization of the Nutrient Requirements for CRP-Dependent Protein 
Acetylation 
To determine if CRP regulates protein acetylation in E. coli, we constructed two 
strains: a ∆crp mutant (strain AJW2198, Table 1) transformed with a plasmid (pCRP, 
Table 2) that expresses wild-type CRP to generate the complemented strain (AJW2313, 
Table 1) and the same ∆crp mutant transformed with pDU9 (Table 2) to generate the 
vector control (VC) strain (AJW4524, Table 1). We grew the resultant transformants 
under four conditions: tryptone broth buffered at pH 7 (TB7), TB7 supplemented with 3 
mM cAMP, TB7 supplemented with 0.4% glucose, and TB7 supplemented with both 3 
mM cAMP and 0.4% glucose. We chose these conditions based in part, on the previously 
reported observation that supplementation of TB7 with 0.4% glucose intensifies the 
acetylome, as assessed by anti-acetyllysine Western immunoblot analysis [14]. To the 
glucose-supplemented TB7, we also added 3 mM cAMP. The exogenous cAMP is 
critical because: 1) the transport of exogenous glucose into the cell represses cAMP 
production [155], 2) cAMP must bind to CRP to promote its DNA-binding activity [155], 
and, 3) 3 mM cAMP has been reported to be sufficient to overcome the effects of glucose 
[156, 157]. Following 7.5 hours incubation at 37°C, we harvested cells, prepared whole cell 
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lysates and analyzed changes in the acetylome using anti-acetyllysine Western 
immunoblot analysis.  
When grown in TB7, both the complemented (AJW2313) and non-complemented 
VC (AJW4524) cells showed very little protein acetylation (Figure 6, lane 1 and data not 
shown), similar to previous findings [14]. When grown in TB7 supplemented with 3 mM 
cAMP, complemented cells (lane 2), there was little detectable difference in lysine 
acetylation relative to growth in TB7 (Figure 6). In contrast, supplementation of TB7 
with 0.4% glucose intensified the acetylome (lane 3) (Figure 6), as reported 
previously[14].  Supplementation with both cAMP and glucose, however, resulted in a 
much more intense acetylome (lane 4) (Figure 6).   
To determine if CRP regulates this glucose- and cAMP-dependent acetylome, we 
compared the acetylation profiles of the complemented strain (Figure 1, lane 4) and its 
VC (Δcrp) (Figure 6). If CRP regulates protein acetylation, we reasoned that the VC 
would exhibit decreased protein acetylation relative to the complemented strain. Indeed, 
most of the glucose- and cAMP-dependent acetylome was decreased or undetectable in 
the VC, supporting the hypothesis that CRP is required for much of the glucose- and 
cAMP-dependent protein acetylation (Figure 6). CRP also appeared to be required for 
some glucose-dependent, but cAMP-independent, acetylations, as the acetylation signal 
of some bands present in the glucose-dependent acetylome (Figure 6, lane 3), was not 
detected in the cAMP-dependent acetylome (Figure 6, lane 2).  Finally, some protein 
acetylation did not require CRP, as the acetylation signal of at least one band did not 
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change with the status of crp. We conclude that the E. coli acetylome varies relative to 
both growth conditions and crp status.  
Glucose is a catabolite-repressing carbon source [155]. To determine if the CRP-
dependent acetylome responds specifically to catabolite repression, we tested diverse 
carbon sources, chosen on the basis of their catabolite repression abilities: glucose and 
pyruvate are strong catabolite repressors, sorbitol and glycerol are moderate catabolite 
repressors, while succinate, lactate, and acetate are poor catabolite repressors. We added 
each carbon source to TB7 supplemented with or without 3 mM cAMP, grew the 
complemented strain and its VC for 7.5 hours at 37°C, harvested cells, prepared cell 
lysates, and assessed changes in global lysine acetylation by anti-acetyllysine Western 
immunoblot analysis. 
Like glucose (Figure 7a, lane 1), sorbitol (Figure 7a, lanes 3 and 4), pyruvate 
(Figure 7a, lanes 6 and 7), and succinate (Figure 7a, lanes 15 and 16) supported robust 
protein acetylation only in the presence of cAMP. In contrast, acetate, glycerol and 
lactate supported robust protein acetylation in the absence of cAMP (Figure 7a, lanes 9, 
12, and 18, respectively). When cAMP was present, glycerol (Figure 7a, lane 13) and 
lactate (Figure 7a, lane 18), but not acetate (Figure 7a, lane 9), supported additional 
acetylation. Like glucose (Figure 7a, lane 2), other carbon source-induced protein 
acetylation depended on CRP (Figure 7a, lanes 5, 8, 11, 14, 17 and 20). We conclude 
that CRP-dependent protein acetylation during growth in TB7 requires some additional 
carbon source and that this behavior is not a direct consequence of catabolite repression,  
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Figure 6. CRP regulates protein acetylation in E. coli. Western immunoblot analyses of 
whole cell lysates from cells grown at 37oC with aeration in TB buffered at pH7 (TB7) 
supplemented with either 0.4% glucose, 3 mM cAMP, or both. Δcrp VC cells (rightmost 
lane) or Δcrp cells complemented with pCRP (lanes 1-4). 
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but that catabolite repression must be overcome to permit binding of CRP to its DNA 
sites. 
Since TB7 is a mixed amino acid-based medium, we asked if the CRP-dependent 
acetylome requires growth on amino acids. To test the role of amino acids, we grew 
complemented cells in MOPS minimal media supplemented with or without casamino 
acids. Both glycerol and glucose supported an acetylome similar to that observed in TB7 
but only in the presence of casamino acids (Figure 7b). The addition of casamino acids 
alone resulted in little acetylation, similar to TB7 alone (Figure 6, lane 1). Thus, we 
conclude that CRP-dependent protein acetylation requires both amino acids and an 
additional carbon source. 
Taken together, these findings support the hypothesis that the central carbon 
regulator CRP regulates protein acetylation in E. coli under certain environmental 
conditions, and suggests a novel link between central metabolism and the regulation of 
protein acetylation.  
 
Determination if Lysine Acetylation involves the Activating Regions of CRP 
Since we had shown that CRP could regulate protein acetylation in E. coli, we 
aimed to elucidate the mechanism underlying this regulation. CRP is a global 
transcription factor that regulates gene expression of over 200 genes in E. coli [123, 124, 131, 
158]. Much of this regulation depends on CRP’s activation regions (ARs), surface-exposed 
patches that permit CRP to make contact with RNA polymerase (RNAP) (Figure 4A) 
[158]. AR1 and AR2 are required for CRP-activated transcription from Class I and Class II 
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Figure 7: CRP regulates protein acetylation in E. coli in multiple carbon sources. 
Western immunoblot analyses of whole cell lysates of A) Δcrp or Δcrp cells 
complemented with pCRP grown at 37oC with aeration in TB buffered at pH7 (TB7) or 
in TB7 supplemented with various carbon sources or both the indicated carbon source 
and 3 mM cAMP, or B) Δcrp cells complemented with pCRP grown at 37oC with 
aeration in MOPS casamino acids (lane 1), MOPS casamino acids supplemented with 3 
mM cAMP (lane 2), MOPS casamino acids supplemented with 0.4% glucose (lane 3), 
MOPS casamino acids supplemented with both 0.4% glucose and 3 mM cAMP (lane 4). 
Lane 5 represents Δcrp cells grown in MOPS casamino acids supplemented with both 
0.4% glucose and 3 mM cAMP (same treatment as lane 4).  
B. 
A. 
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promoters, respectively (Figure 4B, 4C) [123]. At some Class II promoters, AR1 also 
contributes to CRP-dependent transcription [126, 128-131].  
To elucidate the mechanism by which CRP regulates protein acetylation, we 
asked if these ARs are required for the CRP-dependent acetylation profile. We introduced 
well-characterized plasmid-borne AR mutants (Table 2) into the ∆crp mutant strain 
(AJW 2198, Table 1), grew the resultant transformants in the 4 growth conditions 
described previously, and used Western immunoblot analysis to evaluate glucose- and 
cAMP-dependent acetylation. If CRP-dependent acetylation depends on either AR, then 
disruption of that AR should result in decreased protein acetylation relative that exhibited 
by cells that express intact WT CRP.  
Indeed, transformants expressing the AR1 mutant (strain AJW3660, Table 1) and 
grown in TB7 supplemented with glucose and cAMP exhibited a significant decrease in 
the acetylome relative to transformants that expressed WT CRP (strain AJW2313) 
(Figure 8). In contrast, transformants expressing the AR2 mutant (strain AJW2314, 
Table 1) exhibited a more moderate decrease in acetylome intensity relative to cells 
expressing WT CRP  (Figure 8). We conclude that glucose- and cAMP-dependent 
acetylation requires AR1 and involves AR2.  
Since Class I promoters require AR1 and Class II promoters require AR2, we 
conclude that multiple CRP-dependent mechanisms regulate glucose- and cAMP-
dependent protein acetylation. These mechanisms could regulate protein acetylation by: 
1) regulating expression of proteins that are post-translationally modified, 2) regulating 
expression of acetylation-regulating enzymes (e.g. KATs and KDACs), or 3) a  
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Figure 8. Both activating regions of CRP regulate CRP-dependent acetylation. Western 
immunoblot analyses of cell lysates from Δcrp cells (leftmost lane marked with Δcrp), or 
Δcrp cells complemented with WT crp allele (pCRP), KE101 mutant allele (AR2) or the 
HL159 mutant allele (AR1) grown at 37oC with aeration in TB buffered at pH7 (TB7) 
supplemented with either 0.4% glucose, 3 mM cAMP, or both.  
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combination of the two, where CRP regulates expression of the proteins that are 
substrates for acetylation, as well as the enzymes that regulate acetylation. 
 
Determination if CRP regulates KAT expression in E. coli 
 Since we obtained evidence that CRP can regulate protein acetylation in vivo, and 
that this acetylation requires the presence of CRP’s activating regions, we next sought to 
determine if CRP regulates protein acetylation by regulating expression of one or more of 
the enzymes that regulate lysine acetylation: i.e., KDACs or KATs. A search through 
previously published global transcriptional analyses revealed evidence that CRP can 
regulate transcription of the genes that encode two putative KATs, YedL, and YjhQ [37]. 
A recent report also suggests that CRP may regulate transcription of yfiQ, which encodes 
the first KAT identified in enteric bacteria [4]. 
 Next, we perused the promoters responsible for expression of these three genes, 
seeking DNA stretches with similarity to the CRP consensus sequence (TGTGA n6 
TCACA). Since none of these promoter regions had been studied previously, the 
transcription start sites were not known. We therefore first sought putative CRP binding 
sites in the promoter regions that drive transcription of yfiQ, yjhQ and yedL. Knowing 
that CRP tends to bind to sites centered about 40 nucleotides (Class II) or 60 nucleotides 
(Class I) upstream of the transcription start site (+1), we next scanned for a putative 
RNAP binding site [126], which contains the -10 hexamer (consensus TATAAT) and often 
a -35 hexamer (TTGACA) positioned 17±1 nucleotides upstream. Utilizing this method, 
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we identified putative CRP binding sites in front two of the KAT genes previously 
identified as putatively regulated by CRP: yjhQ, and yfiQ (Figure 9).  
yjhQ, a putative KAT gene, lies in an operon downstream of yjhX, a gene of 
unknown function. The yjhX promoter is thought to drive yjhQ transcription [159]. 
Overexpression of CRP in a strain deleted for yjhQ (strain AJW4355, Table 1) resulted 
in decreased protein acetylation compared to a strain in which yjhQ was intact (strain 
AJW4526, Table 1), indicating that YjhQ regulates protein acetylation (data not shown). 
We used the previously described bioinformatics approach to determine if CRP could 
regulate the putative KAT YjhQ. Indeed, upstream of the yjhX open reading frame, we 
identified sequences with good similarity to the consensus sequences for the CRP binding 
site (gGgGA n6 TCAtc), the -35 hexamer (ccGACc) and the -10 hexamer (TATcAa). If 
these sequences indeed recruit CRP and RNAP, then the DNA site for CRP would be 
centered at -61.5 relative to the putative +1 (Figure 9A). This would be a Class I 
promoter, requiring AR1 for its activity. Efforts to determine whether these sequences 
constitute a bonafide CRP-dependent Class I promoter are planned.  
A recent report provides evidence that supports the hypothesis that CRP regulates 
transcription of yfiQ[4]. These authors identified a putative CRP site centered at -41.5 base 
pairs upstream of the putative +1. We verified the existence of this sequence (Figure 9B). 
However, since this would be a Class II promoter requiring AR2 for its activity and we 
had found that that CRP-dependent protein acetylation did not require AR2, we sought 
other putative CRP binding sites. Because yfiQ lies in a putative operon with yfiP [4, 159], a 
gene of unknown function, we analyzed the sequence upstream of the  
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C. 
A. 
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Figure 9. Bioinformatic analyses of the yjhQ, yfiP, and yfiQ promoter regions. The 
transcription start site is marked with a +1, and the dots above the sequences are 10 base 
pairs apart. The putative CRP binding sites are shown in orange, with the CRP consensus 
sequence below in pink. The putative -10 and -35 hexamers are in green, with their 
respective consensus sequences below in pink. A) The yjhX promoter (which drives 
yjhPQ transcription) is shown. A putative CRP binding site centered at -41.5 and a 
second putative site centered at -140.5 are shown. B) The yfiQ promoter. A close-to-
consensus CRP site centered at -41.5 is shown, along with a second putative, lower 
consensus CRP binding site centered at -145.5. C) The yfiP promoter (which drives 
transcription of both yfiP & yfiQ transcription) is shown. A putative CRP site centered at 
-61.5 is shown, along with a second putative, lower consensus CRP binding site centered 
at -95.5.  
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yfiP open reading and identified a putative CRP binding site centered at -61.5 base pairs 
upstream of the putative +1 (Figure 9C). Thus, CRP has the potential to regulate yfiQ 
expression by two mechanisms: regulation of yfiPQ transcription in an AR1-dependent 
manner, and regulation of yfiQ transcription in an AR2-dependent manner.  
Using the same bioinformatics approach, we found no evidence that CRP 
regulates transcription of cobB, which encodes the only KDAC identified in E. coli. 
While it remains to be determined in vivo if CRP does indeed regulate expression of 
either yfiQ or yjhQ, we have bioinformatic evidence that CRP could regulate protein 
acetylation in E. coli by regulating the genes that encode a putative (YjhQ) and a known 
KAT (YfiQ). 
 
Identification of the Targets of CRP/Glucose/cAMP-Dependent Protein Acetylation 
To determine if CRP has the potential to regulate protein acetylation in E. coli, we 
used anti-acetyllysine Western immunoblot analyses to identify any lysine acetylations 
that may be regulated by CRP (Figure 6). Using this approach, we determined that CRP 
does indeed regulate protein acetylation, but were unable to identify the targets of CRP-
dependent protein acetylation.  
To identify CRP-dependent acetylations, we utilized a mass spectrometry 
approach. We grew the complemented strain (strain AJW2313) and its VC (strain 
AJW4524) in TB7 supplemented with glucose and cAMP, separated the proteins by 
SDS-PAGE, and sent the samples to our collaborator Haike Antelmann, who used linear 
trap quadrupole (LTQ) Orbitrap mass spectrometry (MS) to detect acetylated peptides. 
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Dr. Antelmann and her group mapped 18 acetylation sites to 16 different proteins from 
whole cell protein preparations of the complemented strain (Table 4). 
In contrast, from the VC, they mapped only three acetylations (Table 4); each of 
these three acetylations was also detected in the complemented strain. Of the acetylated 
proteins detected solely in the complemented strain, we identified proteins involved in at 
least seven different cellular functions. The most prominently represented function was 
central metabolism. Other acetylated proteins function in translation, transcription, and 
regulation of redox state (Table 4).  
Although these data do not provide direct evidence that CRP regulates acetylation 
of these proteins, the data supports the model that CRP contributes to the acetylation of 
multiple proteins, including several metabolic enzymes. 
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Table 4: Glucose- and cAMP-dependent protein acetylations detected in WT cells but 
not in crp mutant cells. Mass spectrometry was used to identify acetylated peptides in 
∆crp VC and ∆crp pDCRP cells grown in TB7 supplemented with 0.4% glucose and 3 
mM cAMP. There are six functional classes of proteins acetylated in a CRP-dependent 
manner, as assessed by mass spectrometry. The proteins listed in red were found 
acetylated in both the ∆crp VC and ∆crp pDCRP cells.  
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Summary 
To date, very little is known about the regulation and effects of protein acetylation 
in bacteria. While our lab and a few others have studied the regulation and consequences 
of lysine acetylation for a few proteins (i.e. RcsB, RNAP, Acs, CheY and RNase R), the 
majority of protein acetylations in E. coli remain uncharacterized.  
The work described in this chapter aimed to understand CRP-dependent 
regulation of protein acetylation. We hypothesized that CRP helps to regulate protein 
acetylation in E. coli on the basis of published reports that: 1) CRP itself is acetylated, 
and 2) that CRP can regulate transcription of two putative (yedL and yjhQ) and one 
known KATs (yfiQ). Using anti-acetyllysine Western immunoblot analyses, we 
determined that CRP can regulate protein acetylation in vivo, and that CRP-dependent 
protein acetylation was only detected when cells were grown in amino acid rich media 
supplemented with excess carbon. We next assessed the mechanism by which CRP 
regulates protein acetylation and determined that the activating regions of CRP are both 
involved, with AR1 required for the response, and AR2 involved. We hypothesized that 
CRP may regulate protein acetylation by controlling expression of a KAT or a KDAC, 
the enzymes that regulate acetylation. Indeed, we identified putative CRP binding sites in 
front of the promoters that transcribe the genes that encode two KATs, YjhQ and YfiQ, 
suggesting that CRP regulates protein acetylation by regulating the expression of one or 
more KATs. To identify CRP-dependent acetylations, we used mass spectrometry and 
found several proteins whose acetylations seem to be affected by CRP. These data 
support the hypothesis that CRP regulates protein acetylation in E. coli, and that CRP 
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likely regulates acetylation by regulating expression of one or more KATs. These 
findings suggest a novel link between the central metabolism and protein acetylation, 
where carbon transport and metabolism controls the concentration of cAMP, which 
facilitates the binding of CRP to its DNA sites, including those that control transcription 
of two KATs. The resultant expression of these KATs could affect protein acetylation 
with potential implications in regulating multiple cellular processes.  
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CHAPTER IV 
 
 
RESULTS: EVIDENCE THAT KATs MAY  
REGULATE CENTRAL METABOLISM 
 
 
KATs are enzymes that use the central metabolic intermediate acetyl-CoA as an 
acetyl donor to acetylate their protein target. The use of acetyl-CoA as the acetyl donor 
provides the cell with the unique ability to sense and respond to changes in central 
metabolic flux [3, 30]. In the last chapter, we showed previously published and nascent 
evidence that together support the hypothesis that CRP regulates transcription of the 
genes that encode two KATs: YjhQ and YfiQ [4, 37]. Wang et al. recently reported that the 
Salmonella enterica KAT Pat (the homolog of YfiQ) somehow senses changes in 
metabolic flux and responds by acetylating a number of key metabolic enzymes. This 
would appear to lead to a change in metabolic activity, as deletion of pat resulted in a 
growth defect when the cells were grown in minimal media supplemented with glucose 
[3]. These and other results implicate acetylation as a key posttranslational regulatory 
mechanism of bacterial central metabolism [1, 2]. We therefore considered the possibility 
that one of the functions of E. coli KATs may be to acetylate metabolic enzymes. We 
further predicted that this acetylation would affect the flux of carbon through central 
metabolism [160, 161]. In this chapter, we will describe analyses designed to determine if 
YfiQ and/or YjhQ have the potential to regulate central metabolism.  
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The Effects of Mutation of yfiQ on Central Metabolism 
To test the hypothesis that YfiQ regulates central metabolism, we used Phenotype 
MicroArrayTM (Biolog, Hayward, CA), an experimental technique that allows for high-
throughput analyses of cellular phenotypes [162]. The Phenotype MicroArrayTM is a broad-
based phenotypic assay of gene function. It utilizes microtiter plates containing a 
different lyophilized carbon source in each of 90 wells. By inoculating each well with a 
strain, one can determine the ability of that cell to grow and respire on each of the 90 
carbon sources. After inoculation, cells are then grown in the microtiter plates at 37oC 
under microaerophilic conditions while the OMNILOG reader records growth and 
tetrazolium reduction readings at 15-minute intervals during the course of the 37-hour 
growth period. We utilized this method to test if deletion of yfiQ affected the ability of E. 
coli to utilize carbon.   
Of the 90 different carbon sources tested, the ∆yfiQ mutant grew and respired 
significantly worse than its WT parent on 20 (Table 5). Of these 20, many require 
gluconeogenesis to support growth and respiration. These include compounds that are 
metabolized to glycolytic intermediates (e.g., D-galactitol, D-galactarate, 5-keto-D-
gluconic acid, dihydroxyacetone and D, L-α-glycerol phosphate). They also include TCA 
intermediates and associated compounds (e.g., D- and L-malic acid, succinic acid, 
fumaric acid, and L-aspartic acid). Growth on each of these compounds requires 
gluconeogenesis, whose end product is glucose-6-phosphate [67-71]. Thus, it was telling 
that the ∆yfiQ mutant grew and respired better than its WT parent on maltotriose, which 
is metabolized directly to glucose-6-phosphate. Taken together, these data are consistent 
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with the hypothesis that the ∆yfiQ mutant is defective for gluconeogenesis. The 
observation that the mutant grew and respired worse than its WT parent on 
gluconeogenic carbon sources and better than its parent on maltotriose suggests the 
possibility that YfiQ regulates the balance between gluconeogenesis and glycolysis, 
perhaps by acetylating one or more central metabolic enzymes. 
The Phenotype MicroArrayTM experiment is performed under microaerophilic 
conditions. To determine if the YfiQ-dependent growth defect was influenced by 
aeration, we grew the ∆yfiQ mutant and its WT parent in TB7 supplemented with glucose 
with either high levels of shaking (250 rpm), medium levels of shaking (100 rpm) or no 
shaking (static cultures). The ∆yfiQ mutant did not exhibit any dramatic growth 
differences in TB7 supplemented with glucose when aeration was altered, suggesting that 
the YfiQ-dependent growth defect seen with the Phenotype MicroArrayTM assay is not 
subject to differences in aeration (Figure 10). These results indicate that YfiQ is active 
regardless of the differences in aeration, though the mechanism of the YfiQ-dependent 
growth defect remains to be elucidated.  
The KAT YfiQ is often thought to function in close opposition to the only known 
KDAC in E. coli CobB [3, 17]. In S. enterica, for example, CobB has been found to 
deacetylate many of the substrates of YfiQ [3, 17], and deletion of ∆cobB results in some 
growth phenotypes that are in opposition to the growth phenotypes exhibited by the 
∆yfiQ mutant [3]. Since YfiQ is often linked to CobB in S. enterica [3], we subjected an 
isogenic cobB mutant to analysis by Phenotype MicroArrayTM, with the expectation that 
if YfiQ and CobB of E. coli work as a binary system, then deletion of cobB should result  
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Table 5. Phenotypes gained and lost by the ∆yfiQ mutant as shown by Biolog 
metabolome analysis. Carbon sources denoted with an (*) indicate gluconeogenic carbon 
sources.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test Metabolite Growth Differencea Mode of Action/Metabolic Pathway 
   
Phenotype Gained by !yfiQ    
   
Maltotriose 61.41 C-Source/Glycolysis, glucose 
   
Phenotypes Lost by !yfiQ    
   
Dulcitol (D-galactitol) -67.09 C-Source/Galactose  
Mucic Acid (D-galactarate) -66.9 C-Source/Galactose 
L-Aspartic Acid -61.9 C-Source/Amino acid, TCA 
L-Malic Acid -54.62 C-Source/TCA 
5-Keto-D-Gluconic Acid -51.52 C-Source 
D,L-a-Glycerol Phosphate -41.61 C-Source/Gluconeogenesis 
Succinic Acid -40.29 C-Source/TCA 
Dihydroxy Acetone -38.24 C-Source 
D,L-Malic Acid -37.24 C-Source/TCA 
D-Alanine -36.88 C-Source/Amino acid, TCA 
Beta-D-Allose -34.19 C-Source 
D-Saccharic Acid -33.11 C-Source 
Fumaric Acid -32.88 C-Source/TCA 
a-Methyl-D-Galactoside -30.11 C-Source/Galactose 
D-Sorbitol -29.37 C-Source 
D-Galactonic Acid-g-Lactone -27.66 C-Source/Galactose 
D-Malic Acid -26.39 C-Source/TCA 
m-Tartaric Acid -24.04 C-Source/TCA 
D-Arabinose -22.08 C-Source 
Bromosuccinic Acid -21.26 C-Source/TCA 
a. Growth differences are determined by measuring the difference in average height of 
the kinetic plots in arbitrary units.  
* 
* 
* 
* 
* * 
* * 
* 
* * 
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Figure 10. Growth curves of ∆yfiQ mutant and its WT parent grown at 37oC with TB7 
supplemented with 0.4% Glucose, under different aeration conditions. The blue lines 
represent the WT, and the red lines represent the ∆yfiQ mutant in each condition. 
Diamonds represent cells grown in high levels of aeration (250 rpm), triangles represent 
cells grown in moderate levels of aeration (100 rpm), and squares represent cells grown 
in static cultures.  
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Table 6. Phenotypes gained and lost by the ∆cobB mutant as shown by Biolog 
metabolome analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
in phenotypes that are similar but opposite to those obtained with the ∆yfiQ mutant 
(Table 5). Surprisingly, the ∆cobB mutant grew and respired as well as its WT parent on 
almost all the 90 tested carbon sources. Only two carbon sources yielded significantly 
different results: the ∆cobB mutant grew and respired better than the WT parent on α-D-
lactose and D-melibiose, which are both disaccharides composed of glucose and 
galactose, indicating perhaps an altered ability of the ∆cobB mutant to catabolize these 
two disaccharides (Table 6). It is not clear whether the ∆cobB mutant is altered in its 
ability to either transport these disaccharides, split them into their component 
monosaccharides, or catabolize these monosaccharides, as the ∆cobB mutant grew 
similarly to its WT parent in both glucose and galactose. The data obtained by the ∆cobB 
mutant Phenotype MicroArrayTM argues against a direct functional linkage, in E. coli, of 
the KDAC CobB and the KAT YfiQ. The lack of direct functional linkage also suggests 
the possibility that one or more presently unidentified KDACs regulate metabolism by 
counterbalancing the action of YfiQ. 
 
 
Preliminary Metabolic Analyses of the Putative KAT YjhQ 
 
In the last chapter, we provided evidence suggesting that the general carbon 
regulator CRP might regulate expression of the putative KAT YjhQ. We therefore asked 
if YjhQ has the potential to regulate carbon metabolism. We reasoned that loss of an 
enzyme that coordinated carbon metabolism would cause a growth defect. To test this 
hypothesis, we grew the ΔyjhQ mutant and its WT parent at 37°C in TB7 supplemented 
with diverse carbon sources. Relative to its WT parent, the ΔyjhQ mutant grew at a more 
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rapid rate in the presence of 0.6% succinate or 0.4% glucose, but not in their absence and 
not when TB7 was supplemented with 0.8% lactate or 15 mM acetate (Figure 11).  
To extend our analysis to a much wider array of carbon sources, we used 
Phenotype MicroArrayTM (Biolog, Hayward, CA). If YjhQ plays a major role in 
coordinating metabolism, we anticipated that the ∆yjhQ mutant would exhibit a defect in 
the utilization of multiple carbon sources. Of the 90 different carbon sources tested, 
however, only 4 supported poor growth and respiration by the ∆yjhQ mutant relative to 
its WT parent: L-arabinose, D-xylose, dihydroxy acetone, and D-tagatose (Table 7). 
Given the growth defects observed in the original experiment, we were a bit surprised by 
the general lack of phenotypes exhibited by the ∆yjhQ mutant in the Phenotype 
MicroArrayTM. We therefore compared experimental conditions. Whereas the earlier 
experiments were performed in large volume cultures that were shaken, the Phenotype 
MicroArrayTM experiment was performed in small volumes that were not shaken. Thus, 
the relative lack of mutant phenotypes in the Phenotype MicroArrayTM experiment could 
be due to decreased oxygenation. We examined this hypothesis by comparing growth 
curves of the ∆yjhQ mutant under several different aeration conditions, either with no 
aeration (static), moderate levels of aeration (100 rpm), or high levels of aeration (250 
rpm). The ∆yjhQ mutant grew more rapidly than its WT parent only when aerated (250 
and 100 rpm) (Figure 12), indicating that the lack of growth phenotypes exhibited by the 
∆yjhQ mutant in the Phenotype MicroArrayTM experiments is likely due to the low levels 
of aeration. Thus, we propose that YjhQ regulates central metabolism under highly 
oxygenated conditions, perhaps by acetylating central metabolic enzymes.  
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Figure 11. Growth curves of ∆yjhQ and its WT parent grown at 37oC with aeration in 
TB7 (A) or supplemented with 0.6% Succinate (B), 0.4% Glucose (C), 0.8% Lactate (D), 
or 15 mM Acetate (E). For comparison, the no supplement growth curves from Panel A 
(black symbols) are shown in Panels B-E. In each panel, the ∆yjhQ mutant is represented 
by squares. The black lines represent growth in unsupplemented TB7; the red lines 
represent growth in TB7 supplemented with a given carbon source. The WT is 
represented by diamonds. The black lines represent growth in unsupplemented TB7; the 
blue lines represent TB7 supplemented with a given carbon source.   
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Table 7. Phenotypes lost by the ∆yjhQ mutant as shown by Biolog metabolome analysis. 
There were no significant phenotypes gained by the ∆yjhQ mutant.  
 
a. Growth differences are determined by measuring the difference in average height of 
the kinetic plots in arbitrary units.  
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Figure 12. Growth curves of ∆yjhQ mutant and its WT parent grown at 37oC with TB7 
supplemented with 0.4% glucose, under different aeration conditions. The blue lines 
represent the WT, and the red lines represent the ∆yjhQ mutant in each condition. 
Diamonds represent cells grown in high levels of aeration (250 rpm), triangles represent 
cells grown in moderate levels of aeration (100 rpm), and squares represent cells grown 
in static cultures.  
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In Vitro Acetylation Analyses of YfiQ and Various Metabolic Enzymes 
On the basis of mass spectrometric and Phenotype MicroArrayTM analysis of the 
∆yfiQ mutant, we hypothesized that the KAT YfiQ acetylates a subset of metabolic 
enzymes and that this acetylation alters the balance between glycolysis and 
gluconeogenesis, favoring the latter. To test this hypothesis, we purified irreversible 
strictly glycolytic, irreversible strictly gluconeogenic, and reversible bifunctional 
glycolytic/gluconeogenic enzymes (Table 8), used the purified enzymes as putative 
substrates for YfiQ, tested the ability of YfiQ to acetylate the purified metabolic enzymes 
using in vitro acetylation experiments, and monitored metabolic enzyme acetylation 
status by anti-acetyllysine Western immunoblot analysis. As a positive control, we used 
the known YfiQ substrate RcsB (Hu et al., in preparation) [17]. 
When our collaborators (Wayne Anderson’s laboratory at Northwestern 
University) purified these metabolic enzymes, they discovered that some of the proteins 
purified in two peaks, representing different oligomeric states (Table 8). Using size 
exclusion chromatography, they determined that PykA, PykF, LpdA, and Pgk each 
purified as two differently sized oligomers. Currently, we do not know the oligomeric 
forms of these proteins, and this is something the Anderson lab aims to determine in 
future work.  
To monitor acetylation status of the purified proteins, we subjected each form of 
each enzyme to anti-acetyllysine Western immunoblot analysis. Some of enzymes that 
purified in a single state (e.g. fructosebisphosphatase aldolase (Fba) and phosphoenol 
carboxykinase (Pck)) were acetylated in vivo, while others (e.g. triosephosphate 
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Table 8. Summary of in vitro acetylation reactions with YfiQ and various substrates. 
Reactions were run at 37oC for 2 hours, and changes in acetylation status were 
determined using both Western immunoblot analysis and Ellman’s assays (Kuhn et al., in 
preparation; Hu et al., in preparation). The table lists the following results: substrate 
acetylation alone (Kac in vivo), Substrate + acetyl-CoA, and Substrate + acetyl-CoA + 
YfiQ. Y indicates acetylation, N indicates no evidence of substrate acetylation under the 
conditions tested. Certain substrates purified in two different oligomeric states (PykA, 
PykF, LpdA, and Pgk), denoted as (1) or (2), indicating acetylation of either oligomeric 
state 1 or state 2. 
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isomerase (TpiA) and phosphoenolpyruvate carboxylase (Ppc)) were not (Table 8). For 
those that purified in two forms, the acetylation status of both oligomers were either  
similar (e.g. lipoamide dehydrogenase (LpdA) and phosphofructokinase B (PfkB) or not 
((e.g. phosphoglycerate kinase (Pgk) and pyruvate kinase F (PykF)) (Table 8). For 
example, Pgk oligomer 1 was acetylated, while Pgk oligomer 2 was not (data not shown). 
The same was true for PykF. These observations suggest that the oligomer state can 
dictate in vivo acetylation status and perhaps suggest a potential mechanism for the 
regulation of acetylation.  
 To determine if YfiQ is sufficient to acetylate any of the purified metabolic 
enzymes in vitro, we first asked if YfiQ is acetylated in vivo or if it can autoacetylate in 
vitro, similar to what is known about eukaryotic KATs [29, 40]. We reasoned that such a 
finding would help us understand the mechanism by which YfiQ acetylates its target 
substrates. Indeed, purified E. coli YfiQ was acetylated, albeit at low levels (Figure 13) 
(Hu et al., in preparation). We next asked if addition of acetyl-CoA to YfiQ increased 
YfiQ acetylation, and determined that YfiQ has the potential to autoacetylate (Figure 
13). These findings were supported by mass spectrometry, which detected ten acetylated 
lysine residues on YfiQ (Figure 13) (Hu et al., in preparation). We also observed a 40 kD 
protein whose acetylation seemed to require both YfiQ and acetyl-CoA (Figure 13). 
Mass spectrometry identified this protein as the translation factor EF-Tu (data not shown) 
and detected both acetylation of residue K177 in the purified protein and further 
acetylation of K264 after incubation with Acetyl-CoA (Hu et al., in preparation). These 
data confirm reports that EF-Tu is acetylated in vivo [1, 2], and shows that YfiQ may  
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Figure 13.  YfiQ can acetylate in the presence of acetyl-CoA, and can acetylate the 
response regulator RcsB. Data taken from Hu et al., in preparation. In vitro acetylation 
reactions were run at 37oC for 2 hours, and changes in acetylation status were determined 
using Western immunoblot (right) and mass spectrometry (MS) analysis (left).  MS 
analysis identified changes in the acetylation status of various lysines on YfiQ. Peptide 
peak intensity or spectral count analysis shows semi-quantative analyses for changes in 
YfiQ acetylation.  
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be sufficient to acetylate EF-Tu in vitro. Alternatively, EF-Tu could have the potential to 
react with acetyl-CoA independently of YfiQ, either by autoacetylation or by chemical 
acetylation. Thus, in determining if YfiQ is post-translationally modified, we also 
determined that the translation factor EF-Tu co-purifies with YfiQ, and that YfiQ and 
acetyl-CoA or acetyl-CoA alone can induce its acetylation.  
To test our hypothesis that YfiQ acetylates a subset of central metabolic enzymes, 
we incubated each purified protein with acetyl-CoA alone and with both acetyl-CoA and 
YfiQ, and performed anti-acetyllysine Western immunoblot analysis to establish 
acetylation status (Figure 14) or Ellman’s assay (Figure 15) (Kuhn et al., in preparation) 
to monitor CoA evolution. When incubated with acetyl-CoA alone, several proteins (e.g. 
RcsB, PfkA, GapA, and both oligomers of LpdA) became more acetylated (Figure 14, 
Table 8) and evolved more CoA (Figure 15). This suggests the potential for 
autoacetylation, chemical acetylation or contamination with some unidentified 
acetyltransferase. When incubated with both acetyl-CoA and purified YfiQ, only four 
proteins (RcsB, both oligomers of LpdA, PfkA and PfkB) became substantially more 
acetylated (Figure 14) and evolved significantly more CoA (Figure 15) relative to 
incubation with acetyl-CoA alone.  
  Interestingly, all three of the YfiQ-acetylated enzymes, LpdA, PfkA, and PfkB 
are irreversible glycolytic enzymes. Each regulates critical steps of glycolysis: the 
conversion of fructose-6-phosphate to fructose-1,6-bisphosphate (by PfkA and PfkB), 
and the conversion of pyruvate to acetyl-CoA (by LpdA, which is a subunit of the 
pyruvate dehydrogenase complex). Thus, we hypothesize that one or more of these YfiQ-
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dependent acetylations results in the metabolic defect observed with the Phenotype 
MicroArrayTM (Table 5).  We predict that acetylation of PfkA, PfkB and LpdA by YfiQ 
inhibits the activity of these enzymes such that, when yfiQ is absent, glycolysis is favored 
over gluconeogenesis. This would lead to a defect in growth on gluconeogenic carbon 
sources, similar to the results obtained with the ∆yfiQ mutant in the Phenotype 
MicroArrayTM. Thus, YfiQ has the potential to regulate central metabolism by balancing 
carbon flux between glycolysis and gluconeogenesis. Future studies will examine if 
deletion of yfiQ does indeed alter carbon flux through central metabolism, and if YfiQ is 
necessary to acetylate these metabolic enzymes in vivo.    
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Figure 14. Anti-acetyllysine Western immunoblot analyses of in vitro acetylation 
reactions of YfiQ toward metabolic enzyme substrates. Reactions were run for 2 hours at 
37oC with YfiQ and various substrates. A) Acetylation reactions of PfkA, with and 
without YfiQ and acetyl-CoA. B) Acetylation reactions of PfkB peak 1 or peak 2 (which 
represent different oligomeric states), at various concentrations with and without YfiQ 
and acetyl-CoA. C) Acetylation reactions of LpdA peak 1 or peak 2, at various 
concentrations with and without YfiQ and acetyl-CoA. TufA is a contaminant of YfiQ 
purifications (Hu et al., in preparation). 
A B 
C 
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Figure 15. Ellman’s assay measuring activity of YfiQ toward metabolic enzyme 
substrates. The enzyme activity of YfiQ was determined using a discontinuous kinetic 
assay with 82 µg of YfiQ (peak 1), 3 mM substrate and 0.5 mM acetyl-CoA at 37oC for 
two hours. Ellman’s reagent was used to detect the production of CoA at A415nm.  
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Summary 
 In this chapter, we asked if any of the putative CRP-dependent KATs identified in 
Chapter 3 have the potential to regulate central metabolism. Previously, we identified two 
KATs whose expression may be regulated by CRP: the known KAT YfiQ, and the 
putative KAT YjhQ. We hypothesized that the function of these KATs was to acetylate 
metabolic enzymes and alter metabolic homeostasis. We based this hypothesis on our 
preliminary mass spectrometry results, which identified several metabolic enzymes 
whose acetylation was detected when crp was present, but were not detected when crp 
was absent, indicating perhaps that CRP can regulate metabolic enzyme acetylation in E. 
coli. 
 We therefore asked if mutation of either KAT affected the ability of the cells to 
grow and respire carbon. Relative to its WT parent, the ∆yfiQ mutant grew and respired 
poorly on many gluconeogenic carbon sources. In contrast, the mutant grew and respired 
better than its WT parent on maltotriose, which when catabolized directly produces 
glucose-6-phosphate, the end product of gluconeogenesis. Since the mutant grew and 
respired better on maltotriose, we hypothesized that YfiQ controls the balance between 
glycolysis and gluconeogenesis. In contrast, mutation of yjhQ resulted in a growth defect 
in TB7 supplemented with glucose or succinate, and this growth defect required high 
levels of aeration. It is not clear from our experiments if YjhQ functions to regulate 
metabolism. We also tested if mutation of the only known KDAC, CobB, affected carbon 
utilization, and determined that mutation of cobB had little effect on the ability of the 
cells to grow and respire on all but two of the carbon sources tested.  These results 
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indicate that there may be other deacetylases in E. coli that function to oppose YfiQ 
activity and regulate central metabolism. Indeed, data from our lab suggests the existence 
of novel deacetylases in E. coli (Hu and Wolfe, unpublished data).  
 Using in vitro acetylation analyses with purified YfiQ and potential substrates, we 
determined that YfiQ is sufficient to acetylate three metabolic enzymes: PfkA, PfkB, and 
LpdA, which are all irreversible glycolytic enzymes. Some of the proteins tested 
exhibited acetylation when the proteins were incubated with acetyl-CoA alone in vitro. 
This would suggest the potential for acetylation of proteins without the presence of an 
acetyltransferase, though the mechanism remains unclear. We also discovered that YfiQ 
along with some of the other purified proteins (PfkA, LpdA, RcsB, GapA), purified into 
different peaks, which represent different unidentified oligomeric states of the proteins. 
In some cases, both peaks exhibited the same acetylation profile (LpdA, PfkB); in other 
cases (RcsB), the peaks showed varying acetylation patterns across the different in vitro 
conditions. These results indcate that oligomeric states many dictate protein actylation. 
Taken together, our in vivo and in vitro findings support the hypothesis that acetylation of 
these enzymes by YfiQ has the potential to inhibit enzymatic activity, thereby altering the 
balance between gluconeogenesis and glycolysis, favoring the latter.  
 Future studies should utilize metabolic flux analyses to determine if deletion of 
yfiQ does indeed alter carbon flux through central metabolism in E. coli, as has already 
been shown in S. enterica [3], and whether mutation of the YfiQ-acetylated lysine on the 
metabolic enzymes does indeed alter enzymatic activity. Additionally, it remains to be 
determined if YjhQ is sufficient to acetylate proteins.   
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CHAPTER V 
 
 
RESULTS: CRP ACETYLATION AND ITS IMPACT ON GENE EXPRESSION 
 
 
The first report, in 2008, of a posttranslational modification of the global 
transcriptional regulator CRP used mass spectrometry to identify acetylation of K52 of 
CRP [2]. Shortly thereafter, K101 of CRP also was identified as acetylated [1], indicating 
that CRP could become acetylated on multiple lysines in vivo. In our previous chapters, 
we aimed to determine if 1) CRP can regulate protein acetylation and 2) if the putative 
CRP-dependent KATs have the potential to regulate central metabolism. In this chapter, 
we aim to: 1) identify the KAT(s) and KDAC(s) that regulate CRP acetylation, 2) 
identify any additional sites of acetylation on CRP and, 3) determine the effects of CRP 
acetylation on CRP-dependent transcriptional activation.   
 
Preliminary Analyses of the Regulation of CRP Acetylation 
 Although it is known that CRP can become acetylated in vivo, it is not known 
how this acetylation is regulated. Thus, we tested whether the KAT YfiQ could regulate 
CRP acetylation. Previously, we and others had determined that CRP may regulate YfiQ 
transcription [4], and we had used in vitro acetylation analyses to determine that YfiQ is 
sufficient to induce acetylation of three metabolic enzymes: PfkA, PfkB, and LpdA. 
Since CRP is thought to regulate YfiQ transcription, we also asked if YfiQ could 
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acetylate its putative transcriptional regulator, CRP. To test if YfiQ can induce CRP 
acetylation, we used the same in vitro acetylation analyses described previously 
(Materials and Methods and Chapter 4).  
 Purified CRP showed little to no acetylation when assessed by anti-acetyllysine 
Western immunoblot analysis (Figure 16). When acetyl-CoA was incubated with CRP, 
the acetylation state of CRP increased, indicating that CRP may have the potential to 
autoacetylate or to chemically acetylate. However, when YfiQ was added to acetyl-CoA 
and CRP, the acetylation state of CRP increased significantly (Figures 15, 16). These 
results were confirmed by an independent, quantitative approach using the Ellman’s 
assay to detect CoA evolution (Figure 15). Currently, we do not know the sites of YfiQ-
dependent acetylation, but mass spectrometry to identify the YfiQ-dependent lysine 
acetylations on CRP is planned.  
We conclude that the KAT YfiQ is sufficient to induce CRP acetylation. Since 
CRP controls the transcription of many genes, CRP acetylation has the potential to alter 
global gene expression. Because CRP likely regulates transcription of yfiQ and YfiQ 
acetylates CRP, there may be an auto-regulatory loop between CRP and YfiQ that might 
play a homeostatic role (Figure 22).  
 
Summary of the Identified Sites of CRP Acetylation 
Acetylation of CRP was first identified in 2008 by mass spectrometry analysis, 
where acetylation of K52 was identified in stationary but not exponential phase Luria 
broth (LB) cultures [2]. Acetylation of K101 was identified a year later in exponential  
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Figure 16: YfiQ acetylates the global regulator CRP. Anti-acetyllysine Western 
immunoblot analysis of in vitro acetylation assays with YfiQ and CRP. In vitro 
acetylation reactions were run for 2 hours at 37oC, with either YfiQ, CRP, or acetyl-CoA 
added to each reaction.  
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phase LB cultures [1]. In Chapter 3, we described a combination of approaches that helped 
us determine that CRP has the potential to regulate protein acetylation. During that study, 
we used mass spectrometry analysis to compare the acetylation status of proteins between 
Δcrp mutant cells either complemented with CRP (AJW 2313) or carrying the vector 
control plasmid (AJW 4524), each grown in TB7 supplemented with 0.4% glucose and 3 
mM cAMP. We identified 20 proteins whose acetylations were present in the 
complemented cells but not identified in the vector control cells. One of these proteins 
was CRP: we identified three novel acetylation sites on CRP: K27, K36, K153. We also 
identified acetylation of K101, whose acetylation was previously shown to occur during 
exponential phase growth in LB media [1]. We did not observe acetylation of K52, which 
was previously reported [2]. Therefore, of the 15 lysines in CRP, 5 have been detected as 
acetylated, indicating that CRP can be acetylated on multiple lysines under different 
growth conditions (Figure 17). Of the 5 sites of CRP acetylation, K52 and K101 are 
located on RNA polymerase interaction surfaces, and thus are of great interest. The 
effects of acetylation of these two sites will be explored in further detail.  
 
Preliminary Analyses of the Affects of K52 Acetylation on CRP-Dependent 
Transcriptional Activation  
 K52 of CRP is located in a patch of residues of CRP known as Activating Region 3 
(AR3). AR3 is thought to play an inhibitory role in the interaction between CRP and 
RNAP [130] as the positively charged K52 forms a salt bridge with negatively charged 
amino acid, masking the negatively charged AR3 and preventing interaction with a  
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Figure 17. Locations of the five acetylated lysines on CRP. K101 and K52 are the two 
acetylations that are located directly within activating regions. Acetylated lysines are 
shown in orange. Activating region residues are underlined and colored (green AR1, red 
AR2, blue AR3). Notice that the AR2 residues (2 histidine, 1 glutamate and 1 lysine) are 
distantly located in the primary sequence.  
 
86 
 
positively charged surface of RNAP (Figure 5). Previous research has shown that 
mutation of the positively charged K52 residue to an uncharged asparagine (N52) results 
in a tighter interaction between CRP & RNAP, presumably because it permits the 
negatively charged residues on CRP to interact with the positively charged residues on  
RNAP [130]. Thus, neutralization of the charged K52 permits a tighter interaction between 
the two proteins. Acetylation of K52 would neutralize the charge of the lysine. Since K52 
acetylation had been reported [2], we hypothesized that K52 acetylation could play a 
physiologically relevant role similar to that of the K52N mutation; by neutralizing the 
charge of K52, acetylation would permit a tighter RNAP-CRP interaction, and lead to a 
change in gene expression.  
 We chose to test this hypothesis in the context of the acs205 promoter (Pacs205) 
for the following reasons: 1) acs encodes acetyl-CoA synthetase (Acs), an enzyme that 
synthesizes acetyl-CoA from acetate [21]; 2) reversible acetylation regulates Acs enzyme 
activity [21]; 3) CRP is required to activate acs transcription [150]; and 4) the CRP K52N 
mutant actively inhibits transcription from Pacs205, a truncated form of the acs promoter 
that is primarily regulated by CRP [150]. We used TB7 supplemented with glucose and 
cAMP as a stimulus because the addition of glucose to TB7 leads to an increase in the 
acetylation of proteins [14]. Using Pacs205, we tested the following predictions: 1) The 
addition of glucose and cAMP will result in a decrease in CRP-dependent transcription, 
2) mutation of K52 will alter the CRP-dependent transcriptional response to glucose and 
cAMP, and 3) manipulation of the acetyl-CoA:CoA ratio will alter the activity of CRP, 
and result in a change in transcription from Pacs205.  
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 To monitor the effect of glucose and cAMP addition on CRP activity, we 
introduced an Pacs205-lacZ promoter fusion into the CRP complemented strain that had 
been deleted for the lac operon and grew the cells under four different conditions: TB7, 
TB7 supplemented with 3 mM cAMP, TB7 supplemented with 0.4% glucose, and TB7 
supplemented with both glucose and cAMP, as described previously. Indeed, as predicted 
for a catabolite-repressible promoter, growth in the presence of glucose caused a 7-fold 
decrease in acs transcription relative to growth in the absence of glucose (Figure 18). In 
contrast, addition of both cAMP and glucose increased acs transcription by about 2.5-fold 
relative to addition of glucose alone (Figure 18), which returned transcription to the 
unsupplemented level. Thus, cAMP can antagonize the effect of glucose, as predicted by 
their metabolic relationship [156, 157]. This allowed us to test the roles of K52 and acetyl-
CoA in CRP-dependent acs transcription. 
 We used the well-characterized CRP K52N mutant [129, 150] to test the role of K52 
in cAMP-glucose-induced CRP-dependent acs transcription. If the cAMP-glucose-
induced increase in acs transcription involves K52 acetylation, then the K52N 
substitution should result in decreased transcription. Indeed, the K52N mutant 
(AJW2315) exhibited an approximately 2-fold decrease in transcription under conditions 
of high acetyl-CoA:CoA ratio (glucose plus cAMP) relative to transcription in 
unsupplemented TB7 (Figure 19). However, the sole addition of cAMP failed to induce 
transcription of the K52N mutant, indicating that the K52N mutant is unresponsive to 
cAMP addition.  
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Figure 18. CRP responds to the addition of glucose and cAMP. Cells expressing 
pacs205-lacZ reporter fusion were transformed with the plasmid pDCRP (WT CRP). The 
transformants were grown at 37oC with shaking in TB7 (white bar), TB7 supplemented 
with 3 mM cAMP (light grey bar), TB7 supplemented with 0.4% glucose (black bar), or 
TB7 supplemented with 3 mM cAMP and 0.4% glucose (dark grey bar). Cells were 
harvested at regular intervals and OD600 and β-galactosidase activity were measured. The 
highest levels of activity across an 8-hour time course are shown. The mean of three 
independent cultures is shown, and the error bars indicate standard deviations.  
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Figure 19. The K52N mutant of CRP does not respond to the addition of glucose and 
cAMP. Δcrp mutant cells expressing the pacs205-lacZ reporter fusion were transformed 
with the plasmid pDCRP/K52N, expressing the K52N AR3 mutant of CRP. The 
transformants were grown at 37oC with shaking in TB7 (white bar), TB7 supplemented 
with 3 mM cAMP (light grey bar), TB7 supplemented with 0.4% glucose (black bar), or 
TB7 supplemented with 3 mM cAMP and 0.4% glucose (dark grey bar). Cells were 
harvested at regular intervals and OD600 and β-galactosidase activity were measured. The 
highest levels of activity across an 8-hour time course are shown. The mean of three 
independent cultures is shown, and the error bars indicate standard deviations.  
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Since the K52N mutant can activate transcription in TB7 alone, this indicates that 
the mutant can bind to the DNA, but the K52N mutant does not respond to cAMP, which 
we know activates DNA binding of CRP. If the K52N mutant is able to bind the DNA, 
but is unable to activate transcription in the presence of cAMP alone, or glucose and 
cAMP together, this suggests that glucose must have an additional effect on CRP 
independent of K52.   
 If glucose-cAMP-induced acs transcription results from an increase in the acetyl-
CoA:CoA ratio, and if the acetyl-CoA:CoA ratio leads to high levels of acetylation of 
CRP, then decreasing that ratio should eliminate the response to glucose. To achieve this 
reduction, we increased the CoA pool by overexpressing pantothenate kinase (PK), an 
enzyme that catalyzes the first step in CoA synthesis. Overexpression of PK leads to a 3-
fold increase in CoA concentration [163], and this resulted in a decrease in the glucose-
cAMP-induced acs transcription mediated by wild-type CRP (AJW3762) (Figure 20A), 
but had no effect on transcription by the K52N mutant (AJW3764) (Figure 20B). These 
data support the hypothesis that glucose-cAMP-induced acs transcription is sensitive to 
the acetyl-CoA:CoA ratio and are consistent with the hypothesis that acetylation of a 
lysine other than K52 of CRP, a lysine either on CRP or RNAP, is responsible for 
regulating the acs transcription response to glucose and cAMP.  
 Our preliminary studies into the effects of K52 acetylation indicate that: 1) CRP-
dependent acs transcription responds to the addition of glucose and cAMP, which we 
predict leads to an increase in the acetyl-CoA:CoA ratio [14, 163], and the acetylation of 
CRP, 2) that this activity correlates with the acetyl-CoA:CoA ratio, 3) that K52 is  
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Figure 20. Only WT CRP is sensitive to manipulations of Acetyl-CoA and CoA levels. 
Δcrp mutant cells expressing pacs205-lacZ reporter fusion and carrying either WT CRP 
(Panel A), or pDCRP/K52N (Panel B) plasmids, were transformed with the vector 
pCA24N plasmid (black lines), or a pCA24N derivative containing the coaA ORF (red 
lines). The transformants were grown at 37oC with shaking in TB7 (white bar), TB7 
supplemented with 0.4% glucose (black bar), or TB7 supplemented with 3 mM cAMP 
and 0.4% glucose (dark grey bar). 50 µM IPTG was used to induce coaA expression. 
Cells were harvested at regular intervals and OD600 and β-galactosidase activity were 
measured. The highest levels of activity across an 8-hour time course are shown. The 
mean of three independent cultures is shown, and the error bars indicate standard 
deviations. 
A. 
B. 
92 
 
important to regulate acs transcription, but the glucose-cAMP response seems to be 
independent of K52, and 4) that there must be another glucose-cAMP specific acetylation 
of a lysine either on CRP, RNAP or both CRP and RNAP. These results are consistent 
with the hypothesis that glucose and cAMP impact the acetylation status of CRP & that 
this PTM influences CRP function. However, we have yet to determine: 1) how CRP 
acetylation is regulated and 2) how CRP acetylation affects interaction of CRP with RNA 
polymerase. 
 
Preliminary Analyses of the Affects of K101 Acetylation on CRP-Dependent 
Transcriptional Activation  
The transcription data we acquired with the K52N mutant argues against 
acetylation of K52 as the primary actor in the glucose-cAMP-dependent transcriptional 
response. These results suggest that there may be another lysine involved in regulating 
CRP-dependent transcription in the presence of glucose and cAMP. Indeed, published 
reports identified another acetylation of CRP on K101 [1], a lysine found within a surface 
exposed patch of CRP called activating region 2 (AR2). K101 of AR2 is known to make 
direct contact with a negatively charged residue on surface of the N-terminal domain of 
the α subunit of RNAP (α-NTD). This contact is required for transcription from Class II 
promoters [128] (Figure 4). At CRP-dependent Class II promoters, CRP binds at a site near 
the -35 hexamer and interacts with the α-NTD of RNAP using the AR1 and AR2 surfaces 
[126].  
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Disruption of the charge on either CRP or the α-NTD results in a loss of 
transcription from Class II promoters, indicating that these charge-charge interactions are 
required for transcriptional activation [128]. Acetylation of a lysine neutralizes its charge, 
which in the case of K101 would result in loss of a positive charge of the AR2 surface. 
Indeed, both reversal of charge (K101E) and loss of charge (K101A) result in complete 
loss of transcription from Class II promoters [128], indicating that K101 is critical for Class 
II-CRP-dependent transcription. Based on the previously published results, we 
hypothesized that the acetylation of K101 would disrupt the charge-charge interaction 
between AR2 of CRP and the α-NTD of RNAP, thereby affecting transcription from 
Class II promoters.  
To test the hypothesis that K101 acetylation affects CRP-dependent Class II 
transcription, we have constructed acetylated lysine mimics of K101, similar to those 
used in the well-studied field of histone acetylation [164]. In this approach, the lysine is 
converted either to a glutamine (Q) to mimic an acetylated lysine, or converted to an 
arginine (R) to mimic an unacetylated lysine (Strains listed in Table 1). We used the 
well-characterized semi-synthetic CC-41.5-lacZ promoter [165, 166] as the readout for CRP 
activity at a Class II promoter. If acetylation of K101 affects the charge-charge 
interaction between CRP and the α-NTD of RNAP, then the K101Q mutation should 
disrupt this interaction and diminish transcription, while the K101R mutation should 
behave more like WT, since arginine carries the same charge properties as an 
unacetylated lysine.  
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Preliminary experiments suggest that the charge of K101 is indeed important in 
regulating CC-41.5 transcription, but it is unclear how mutation of K101 to K101Q 
affects transcription from this promoter. The K101E mutant which is known to disrupt 
transcription from the CC-41.5 promoter, failed to do so in our experiment, rendering the 
results of the K101Q, R, and A mutants unreadable. We however can say that mutation of 
K101 to K101Q, R, and A does not affect DNA binding of these CRP variants, as all of 
the K101 variants have levels of transcription that were comparable to WT (Figure 21). 
Surprisingly, none of the mutants exhibited any significant changes in transcription when 
compared to transcription with WT CRP. 
These experiments were performed in unsupplemented TB7, and future studies 
must investigate transcriptional activation of WT CRP and the K101 variants when cells 
are grown in TB7 supplemented with 0.4% glucose and 3 mM cAMP; a growth condition 
shown to induce K101 acetylation (see Summary of the Identified Sites of CRP 
Acetylation section above). Thus, it is possible then that we were unable to detect 
differences in transcription due to the lack of induction of CRP acetylation. Future studies 
must also determine which KATs and KDAC, if any, regulate K101 acetylation, and 
determine if K101 acetylation affects the interaction between CRP and RNA polymerase.  
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Figure 21. Mutation of K101 and the response from the CC-41.5 promoter. Cells 
expressing pCC-41.5-lacZ reporter fusion were transformed with pBR322 vector control 
(red bar) pDCRP (blue bar), pDCRP/K101E (pink bar), pDCRP/K101Q (green bar), 
pDCRP/K101A (purple bar), or pDCRP/K101R (orange bar) plasmids. The transformants 
were grown at 37oC with shaking. Cells were harvested at regular intervals and OD600 
and β-galactosidase activity were measured. The highest levels of activity across an 8-
hour time course are shown. The mean of three independent cultures is shown, and the 
error bars indicate standard deviations. 
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Summary 
 In this chapter, we assessed the regulation and transcriptional effects of CRP 
acetylation. Previously, two lysines on CRP had been identified as acetylated: K52 and 
K101 [1, 2]. Our studies confirmed acetylation of K101 and identified 3 new sites of 
acetylation: K27, K36, and K153. The putative CRP-dependent KAT, YfiQ was 
sufficient to induce CRP acetylation, although the lysines whose acetylations are YfiQ-
dependent remain to be identified.  
We hypothesized that the functions of two of the acetylations, K52 and K101, 
were to neutralize the charge and thereby alter interactions between CRP and RNA 
polymerase, affecting transcription from various CRP-dependent promoters. We 
predicted that acetylation of K101 would result in a decrease in interactions between CRP 
and RNAP, and acetylation of K52 would result in the opposite – increased interactions 
between CRP and RNAP. Preliminary evidence using transcriptional assays suggests that 
the charges of both these lysines are required for transcription from the two promoters 
assayed in this study, and acetylation of these lysines is likely to have an affect on CRP-
dependent transcription. Although we have yet to identify a clear effect of these 
acetylations on CRP-dependent transcription, we have strong preliminary evidence that 
supports the merit of our hypothesis that acetylation of CRP affects CRP-dependent 
transcriptional activation. This hypothesis will be extensively tested in future studies.  
  
 97 
CHAPTER VI 
 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 
The discovery of large-scale protein lysine acetylation in bacteria has spurred a 
new field: the study of the regulation and effects of bacterial protein acetylation. To date, 
however, the acetylation of only five proteins in E. coli have been studied in any depth: 
CheY, Acs, RNAP, RcsB, and RNase R [8-17].  
Of the more than 200 E. coli proteins with detectable acetylations, many are 
central metabolic enzymes [1, 2]. Some evidence exists that suggests that acetylation can 
affect metabolic enzyme function in bacteria [3, 15, 22]. On this basis, acetylation is 
predicted to affect carbon flux through central metabolism [3]. However, much remains to 
be discovered.  
Preliminary evidence suggests that CRP may regulate protein acetylation in E. 
coli. One study has shown that CRP can regulate transcription of two putative KATs in 
vitro [37]. Another reports that cAMP, the allosteric effector of CRP, can regulate 
expression yfiQ, which encodes the only studied KAT in E. coli [4].  
The goal in this study was to determine if CRP actually regulates protein 
acetylation in E. coli, and to gain insight into the mechanism(s) by which this regulation 
might occur. We also aimed to understand the regulation of metabolic enzyme acetylation 
and some of the downstream effects of that acetylation. We hypothesized that CRP would 
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regulate protein acetylation, that one or more KAT might regulate acetylation of central 
metabolic enzymes and that acetylation of at least one central metabolic enzyme would 
impact carbon flux.   
 Using both in vivo and in vitro approaches, we determined that CRP does indeed 
regulate protein acetylation in E. coli, most likely by regulating the expression of one or 
more KATs. We also determined that at least one of these putative-CRP dependent 
KATs, YfiQ, is sufficient to acetylate several metabolic enzymes. One is lipoamide 
dehydrogenase (LpdA), a subunit of both the pyruvate dehydrogenase complex (PDHC) 
and α-ketoglutarate dehydrogenase, which synthesize acetyl-CoA and succinyl-CoA, 
respectively. The others are both phosphofructokinases PfkA and PfkB, which convert 
fructose-6-phosphate to fructose-1,6-bisphosphate. All three are irreversible glycolytic 
enzymes. Since, deletion of yfiQ resulted in a growth defect on over 20 mostly 
gluconeogenic carbon sources, we hypothesized that CRP- and YfiQ-dependent protein 
acetylation of certain strictly glycolytic enzymes shifts central metabolic equilibrium 
towards gluconeogenesis.  
We also began to study the downstream effects of CRP acetylation. Although no 
conclusive evidence was obtained, the preliminary results support the hypothesis that 
acetylation of certain lysines on the surface of CRP has the potential to impact CRP-
dependent Class II promoter activity.  
The implications of this work and future directions for this study will be 
elaborated in the following sections.  
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Nutritional requirements for CRP-dependent protein acetylation 
To test the role of CRP in controlling protein acetylation, we first determined the 
nutritional requirements for CRP-regulated acetylation, finding that acetylation required 
growth on both amino acids and carbon sources that feed into central metabolism. 
Growth on amino acids or carbon sources alone did not stimulate CRP-dependent 
acetylation (Figures 6 and 7). Previous research from our lab had shown that the 
addition of glucose to TB7 induces protein acetylation [14]. The work presented in the 
thesis verifies that finding and furthers it by identifying additional carbon sources that 
can induce protein acetylation (Figure 7).  
This protein acetylation does not require catabolite repression, as growth on either 
catabolite repressing (e.g. glucose) or non-catabolite repressing (e.g. acetate) carbon 
sources produced similar acetylation patterns (Figure 7). These results also provide 
additional evidence for the hypothesis that the critical element is the acetyl-donor, acetyl-
CoA [14, 167]. Transcriptional evidence from our lab suggests that it is the acetyl-CoA:CoA 
ratio that is important, as decreasing acetyl-CoA or increasing CoA concentrations have a 
similar effect [14]. Further work must be done to fully understand the growth requirements 
for acetylation. For example, what is the role of the amino acids? Which amino acids are 
critical? Does acetyl-CoA concentration or the acetyl-CoA:CoA ratio affect the activity 
of KATs or KDACs? Indeed, a recent publication reported that acetyl-CoA activates, 
while CoA inhibits the activity of certain eukaryotic KDACs [168].  
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CRP-dependent regulation of protein acetylation in E. coli 
No definitive studies exist showing that CRP can regulate protein acetylation in E. 
coli. While evidence exists to support the hypothesis, it is correlative at best. For 
example, one study shows that CRP is sufficient to activate in vitro transcription of two 
putative KATs: yjhQ and yedL [37]. Another study reports that exogenous cAMP 
stimulates transcription from a promoter that drives transcription of yfiQ, which encodes 
a known KAT [4]. Taken together, these two studies raise the possibility that CRP may 
regulate protein acetylation.  
We have extended these studies, using anti-acetyllysine Western immunoblot 
analysis to identify the nutritional requirements for CRP-dependent protein acetylation in 
vivo, to show that CRP regulates protein acetylation in E. coli, and to demonstrate that 
both CRP activating regions regulate CRP-, glucose-, and cAMP-dependent acetylation: 
while activating region 1 is required, activating region 2 contributes (Figure 8). The 
identification of sequences that resemble the consensus CRP binding site located 
upstream of yfiQ and yjhQ (Figure 9) strengthens the hypothesis that CRP could regulate 
protein acetylation in E. coli by regulating expression of KATs. 
While all the available evidence supports the hypothesis that CRP regulates 
protein acetylation in E. coli, much remains to be determined. For example, there is no 
actual evidence that CRP binds to the identified sequences. Also, while it is clear that 
cAMP regulates yfiQ transcription, no solid evidence shows that this effect requires CRP. 
Furthermore, no in vivo evidence exists to demonstrate that either cAMP or CRP 
regulates yjhQ. Thus, future studies should determine if CRP controls the transcription of 
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any of the other known or putative KATs. If not, future studies should determine how 
CRP influences protein acetylation in vivo and elucidate the mechanisms by which KAT 
transcription is regulated.  
This putative link between cAMP via CRP and KAT regulation is exciting. 
Evidence for a similar system exists in other bacteria. Work done in Mycobacterium 
tuberculosis and Mycobacterium smegmatis indicates that cAMP regulates protein 
acetylation in these bacteria by directly regulating KAT activity [38, 169]. MSMEG_5458 
and its homolog in M. tuberculosis are composed of a cAMP-binding domain fused to a 
KAT domain that can acetylate Acs. Thus, in response to cAMP, these KATs acetylate 
Acs [38, 169]. Could we be looking at a similar but less hard-wired relationship, where 
cAMP binds the transcription factor CRP, to activate transcription of KAT-encoding 
genes? If so, it is intriguing that YfiQ acetylates Acs, whose gene is transcribed in a 
strictly cAMP- and CRP-dependent manner.   
 
Metabolic Enzyme Acetylation in E. coli 
Acetylation of acetyl-CoA synthetase (Acs) was the first reported and best-studied 
acetylation of a bacterial metabolic enzyme [15, 16]. Since these studies, however, 
proteomics studies using mass spectrometry have identified many additional acetylations 
of metabolic enzymes [1-3]. Indeed, acetylation occurs on most of the central metabolic 
enzymes of E. coli and S. enterica. Acetylation was detected on all of the enzymes 
involved in glycolysis, except two (glucokinase and phosphofructokinase). Acetylation 
also was detected on two gluconeogenic enzymes (phosphoenolpyruvate carboxykinase 
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and aldolase). Finally, acetylation was detected on several TCA cycle enzymes (citrate 
synthase, isocitrate lyase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, 
succinate dehydrogenase) [1-3]. Although the YfiQ homolog of S. enterica (Pat) was 
shown to acetylate GapA, Acs, AceE, and AceK [3], it is not known if these events occur 
in E. coli and, if so, whether these acetylations affect carbon flux.  
Our work furthers these studies and provides preliminary insights into how 
acetylation might affect carbon flow through central metabolism. We used mass 
spectrometry analysis to identify several central metabolic enzymes whose acetylation 
was detected when CRP was expressed, but were not detected when CRP was absent 
(Table 4). While non-quantitative, these data are supportive of the hypothesis that CRP 
regulates acetylation of central metabolic enzymes.  
These data and others [3], combined with observations supporting the hypothesis 
that CRP regulates expression of YfiQ, led us to hypothesize that YfiQ may acetylate 
central metabolic enzymes in E. coli. If YfiQ does acetylate metabolic enzymes, and if 
enzyme acetylation affects activity, and therefore carbon flux through central 
metabolism, then deletion of yfiQ should affect the ability of E. coli to utilize and grow 
on different carbon sources. Indeed, deletion of yfiQ did affect the ability of E. coli to 
grow and respire on more than 20 different carbon sources (Table 5). However, it is not 
clear where the defect in metabolism lies. Many of the carbon sources that supported 
poorer growth and respiration of the yfiQ mutant than its WT parent require the 
gluconeogenic pathway. In contrast, the only carbon source that permitted better growth 
and respiration of the yfiQ mutant than its WT parent was maltotriose, which is directly 
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catabolized into glucose-6-phosphate and thus does not require gluconeogenesis. That the 
yfiQ mutant actually fared better than its parent on maltotriose suggests that the WT 
sacrifices some growth to build glucose-6-phosphate and that YfiQ plays a role in 
establishing the proper balance between glycolysis and gluconeogenesis.  
Based on our in vivo mass spectrometry data, the PM array data with the yfiQ 
mutant, and the potential CRP-dependent regulation of yfiQ transcription, we 
hypothesized that YfiQ acetylates metabolic enzymes in E. coli, and that such acetylation 
would alter metabolic flux. We therefore determined if YfiQ (along with its substrate 
acetyl-CoA) is sufficient to acetylate central metabolic enzymes using in vitro acetylation 
reactions, and determined that YfiQ can specifically acetylate three enzymes: lipoamide 
dehydrogenase (LpdA), and the two phosphofructokinases (PfkA, PfkB). All other 
enzymes tested showed no changes in acetylation status when YfiQ was added to the in 
vitro reaction mixture. The finding that YfiQ acetylated only three irreversible glycolytic 
enzymes warrants further investigation into how YfiQ-dependent acetylation of these 
enzymes affects their activity, and whether acetylation of LpdA, PfkA, and/or PfkB 
affects the equilibrium between glycolysis and gluconeogenesis. The combination of the 
PM array data with the acetylation data suggests that acetylations of LpdA, PfkA, and 
PfkB function to inhibit the activity of these enzymes, such that when yfiQ is absent, 
glycolysis is favored over gluconeogenesis. 
These results differ from the findings of Wang et al., who showed that deletion of 
pat from S. enterica leads to a 40.7% decrease in the glycolysis/gluconeogenesis flux 
ratio when compared to WT [3]. Thus, when pat is absent, gluconeogenesis is favored 
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over glycolysis. This would imply that Pat-dependent acetylation of metabolic enzymes 
activates glycolysis, perhaps by acetylating the reversible glycolytic/gluconeogenic 
enzyme GapA and favoring its glycolytic activity [3]. We found the opposite in E. coli; 
deletion of yfiQ appeared to disfavor gluconeogenesis and reversible GapA did not 
appear to be specifically acetylated by YfiQ. Instead, the YfiQ-dependent acetylations 
were on strictly glycolytic enzymes. Could Pat and YfiQ, which contain 92% amino acid 
similarity, function differently in S. enterica and E. coli, respectively?   
During the course of the in vitro experiments, we discovered that six of the 
fourteen enzymes tested acetylated in vitro in the presence of acetyl-CoA alone (Table 
8). It is possible that the purification preparations of some metabolic enzymes are 
contaminated with a co-purifying acetyltransferase. It is not clear whether enzyme-
independent acetylation occurs in vivo, and the physiological affects of this type of 
acetylation are not known. Future studies might elucidate whether non-enzymatic 
acetylation of proteins occurs in vivo, and determine the factors that dictate if a protein 
can undergo spontaneous acetylation.   
We also discovered that YfiQ in E. coli can acetylate itself in the presence of 
acetyl-CoA (Figure 13). We do not know if this acetylation of YfiQ affects YfiQ 
structure, substrate recognition, or stability, and thus function of YfiQ. Data from S. 
enterica suggests that Pat also undergoes acetylation in the presence of acetyl-CoA, but 
studies into the thermodynamics and kinetics of Pat activity did not assess if Pat 
acetylation affected KAT activity [17, 32]. Thus, future work must take into account the 
acetylation of YfiQ/Pat and determine if the acetylation affects YfiQ function, similar to 
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the work that has been done to elucidate the effects of acetylation of KATs on KAT 
activity in eukaryotes [40, 41].  
 
Affects and Regulation of CRP Acetylation 
 The acetylation of CRP on two lysine residues deemed critical for transcriptional 
regulation from Class II-CRP dependent promoters was recently discovered [1, 2]. 
Currently, however, there are no studies into the regulation and affects of CRP 
acetylation.  Acetylation of K101 and K52 have the potential to impact transcription by 
disrupting the protein-protein interactions between CRP and RNAP that are necessary for 
transcription from Class II promoters. Currently, there are only two other bacterial 
transcription factors where acetylation has been studied: RNAP and RcsB (Hu et al., in 
preparation) [14, 17], and these studies support the hypothesis that acetylation can disrupt 
interactions between RNAP, transcription factors, and their DNA sites.  
 In our work, we sought to understand the regulation and affects of CRP 
acetylation, and determined that: 1) the KAT YfiQ is sufficient to acetylate CRP, 2) CRP 
acetylation also seems to occur in the presence of acetyl-CoA alone, 3) CRP can become 
acetylated on 5 of its 15 lysines, and 4) acetylation of CRP might alter CRP-dependent 
transcriptional activation.  
 The finding that YfiQ is sufficient to acetylate CRP (Figure 16) is exciting as it 
suggests the possibility of a feedback loop in which CRP regulates YfiQ expression and 
YfiQ acetylates CRP, altering its activity (Figure 22). Studies to test this hypothesis 
should be performed. 
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We currently do not know which lysine acetylations require both YfiQ and acetyl-
CoA and which acetylations require only acetyl-CoA. To identify the locations of these 
acetylations, one would perform mass spectrometry analysis on in vitro acetylated CRP. 
Ultimately, one would want to delineate the impact of these two different types of CRP 
acetylation on CRP-dependent transcription.  
 Previous studies had detected acetylation of K52 and K101. Our preliminary mass 
spectrometry studies of whole cell lysates from WT and complemented CRP cells 
revealed 3 additional sites of CRP acetylation: K27, K36, and K153. These lysines have 
not been implicated in regulating transcription or in affecting cAMP binding to CRP. 
Thus we chose to focus our efforts on the two lysines that are known to affect 
transcription: K52, and K101. However, it is possible that acetylation of K27, K36, and 
K153 or K101 and K52 could affect CRP activity by altering the structure of CRP, which 
would have the potential to disrupt CRP binding: 1) its allosteric affector cAMP, 2) 
consensus sequence on the DNA, or 3) both cAMP and the DNA. Additionally, 
acetylation of CRP could affect stability of the protein, thereby affecting CRP-dependent 
gene expression. These possibilities need to be tested in future studies of CRP 
acetylation.  
 The finding that CRP undergoes acetylation on multiple residues (Figure 17) 
indicates perhaps another regulatory mechanism to regulate CRP activity, the first being 
cAMP binding to CRP. Fluctuations in metabolism, leading to changes in the levels of 
acetyl-CoA, are also thought to affect the acetylation status of proteins in bacteria [30, 161, 
170]. Thus, both cAMP levels and potentially the levels of acetylation are intimately tied to 
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the fluxes in central metabolism [30, 161, 170], indicating that CRP activity may respond in 
multiple ways to changes in metabolic conditions (Figure 22). These multiple layers of 
CRP regulation are necessary since CRP controls expression of around 5% of genes in E. 
coli, and rampant activation of CRP would affect cell growth and viability.  
Thus, the study of the regulation and affects of CRP acetylation is crucial to our 
understanding of the response of E. coli to changes in environmental conditions. Our 
work has given credence to the hypothesis that acetylation of CRP affects CRP-
dependent transcriptional activation.  
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Figure 22. Proposed Model. Based on our work and others [4], we propose a model in 
which the central carbon regulator in E. coli, cAMP receptor protein (CRP) activates 
transcription from promoters located upstream of yfiP and yfiQ. In this model, the GNAT 
YfiQ acetylates various substrates in E. coli, including the metabolic enzymes 
phosphofructokinase (PfkA/PfkB) and lipoamide dehydrogenase (LpdA), the latter a 
subunit of pyruvate dehydrogenase. We predict that YfiQ-dependent acetylation of these 
metabolic enzymes alters their function, shifting the equilibrium between glycolysis and 
gluconeogenesis. We also propose that YfiQ acetylates CRP, altering its function & 
forming an autoregulatory loop. 
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